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ABSTRACT 
Pharmaceuticals and personal care products (PPCPs) are biologically active, 
organic chemicals that are introduced into the environment through wastewater streams. 
These chemicals are being found in the environment in trace concentrations and are of 
concern due to their unknown potential for harm to the health and welfare of the 
environment. The hypothesis is that during the course of wastewater treatment in a 
municipal lagoon system from a small community, PPCPs are seeping into ground water 
resulting in chronic low exposure in the environment. The objective of this work was to 
study a specific wastewater lagoon treatment system in Mountain Home, Idaho and the 
surrounding ground water for PPCPs. Water samples were taken from influent, lagoons, 
and surrounding ground water wells to look for presence of PPCPs. A conceptual model 
of the ground water flow was developed in order to link lagoon seepage to surrounding 
ground water wells. The ground water flow model combined with the sampling data was 
used to show that PPCPs are present in the lagoons and seeping into the ground water in 
very low yet detectable concentrations. PPCPs were detected in the samples from the 
headworks, in the storage lagoon, and in a monitoring well downgradient of the lagoon. 
Twelve PPCPs were tested and eleven were found in the headworks in concentrations up 
to 7,920 ng/L. Seven PPCPs were found in the storage lagoon in concentrations up to 
880 ng/L. Six PPCPs were found in a downgradient monitoring well in concentrations up 
to 82 ng/L. 
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INTRODUCTION AND HYPOTHESIS 
Pharmaceuticals and personal care products (PPCPs) are biologically active, 
organic chemicals found in the environment at trace concentrations (Daughton 2004; 
Kummerer 2004; Heberer 2002; Ternes and Joss 2006; EPA 2008; USGS 2002). Due to 
their unknown potential for carcinogenicity, biological activity, and promotion of 
antibiotic resistance in certain organisms, PPCPs are an emerging concern (Daughton 
2004; EPA 2008; USGS 2002). PPCPs are introduced into wastewater streams through 
household drains and subsequently enter municipal wastewater treatment systems (EPA 
2008; Richards 1996; Bound and Voulvoulis 2005). Subsequently, wastewater enters the 
environment through seepage from all types of treatment facilities or direct discharge of 
treated water to the environment (EPA 2008; Kummerer 2004; Ternes and Joss 2006). 
This transmission of water from household to treatment system to ground water 
represents a major potential pathway for PPCPs to enter the environment (EPA 2008; 
Dingman 2002; Domenico and Schwartz 1998; USGS 2008a). 
While a number of studies have been performed on large municipal treatment 
systems to understand the interactions of PPCPs with the environment, little work has 
been performed to investigate the lagoon style wastewater treatment systems that are 
prevalent throughout the United States (EPA 2002). It is possible that PPCPs are seeping 
into ground water from the wastewater treatment lagoons or land application of treated 
wastewater; however, studies to date linking PPCPs and lagoon seepage are limited 
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(EPA 2007b). It has been hypothesized for this study that during the course of wastewater 
treatment in a lagoon system and subsequent land application of the effluent, some 
PPCPs are seeping into ground water in a form or concentration that can be detected 
using currently available analytical techniques. In addition, wastewater treatment lagoons 
and land application of wastewater form part of the exposure route of trace chemicals in 
the environment. Grab samples of wastewater and area ground water in the vicinity of a 
selected lagoon system have been collected and evaluated for both presence and trend 
analysis of PPCP concentrations as they relate to the site-specific conditions. The results 
will provide information about possible exposure routes of trace chemicals in the 
environment from wastewater treatment lagoons.  
Scope of Thesis 
There are approximately 200 wastewater land application sites permitted by the 
Department of Environmental Quality (DEQ) throughout the state of Idaho; these 
wastewater reuse permits were examined to identify a suitable project site that used 
facultative lagoons as the wastewater treatment process. Once identified, the site was 
researched for historical information on wastewater treatment (flow, lagoon specification, 
detention time, and land application), population base, and site geology (soils, vadose 
zone, aquifer systems, ground water recharge, ground water flow direction, and existing 
wells). The presence and concentrations of PPCPs are known to be influenced by 
economic and demographic structure (Trapp and Matthies 1998) and thus were important 
criteria in the site selection. Water samples were collected before and after wastewater 
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treatment, as well as from ground water. Sample sites included a municipal wastewater 
lagoon and water bodies downgradient from wastewater treatment. Samples were 
analyzed for PPCPs and changes in PPCP concentration from influent to effluent to the 
local ground water system and were evaluated to develop a conceptual model for fate and 
transport of PPCPs. Oxygen and deuterium isotope data were used to determine linkages 
between treatment system sources of the chemicals and the concentrations found in the 
local and regional ground water. These data, along with concentration gradients, were 
used to establish hydraulic connectivity between the wastewater lagoon seepage and 
ground water. A qualitative analysis was performed, excluding a quantitative analysis of 
the transport of the PPCPs from the lagoon due to the limited budget and to limit the 
scope of research. 
Background 
Environmental Pathways for Pharmaceuticals and Personal Care Products  
Trace chemicals that are biologically active in humans and other vertebrates are 
found around the world in very low concentrations in ground water, rivers, lakes and 
coastal waters (EPA 2008; Kummerer 2004; Ternes and Joss 2006). This thesis will focus 
on a subset of these contaminants that includes both pharmaceuticals and personal care 
products (PPCPs). As shown in Figure 1, PPCPs are introduced into wastewater streams 
through household and hospital drains and subsequently enter municipal wastewater 
treatment systems (Richards 1996; Metcalf and Eddy 1991; Bound and Voulvoulis 2005).  
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Figure 1 Pathways for PPCPs (adapted from EPA 2008; Kummerer 2004; 
USGS 2002; Ternes and Joss 2006; Garg and Jha 2005; Heberer 2002) 
Many current wastewater treatment methodologies were not designed to remove 
PPCPs (EPA 2007b; Heberer 2002; Gobel et al. 2007; EPA 2008). Some studies indicate 
that secondary wastewater treatment processes (i.e., activated sludge and membrane 
bioreactors) only partially remove PPCPs (EPA 2007b; Heberer 2002; Gobel et al. 2007; 
EPA 2008). Studies indicate that post-treatment effluents from these processes contain 
PPCPs (EPA 2008; USGS 2008b; Snyder et al. 2004). Information is more limited on the 
fate and transport of PPCPs from facultative treatment lagoons. Because there are over 
7,000 facultative lagoons in use in the United States located in less populated cities and 
towns (EPA 2002), their design and use has led to wastewaters entering the environment 
through seepage from the treatment facilities or direct discharge of treated water to the 
environment (EPA 2008; USGS 2008b). The cycling of water from household to 
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treatment system to ground water represents a major potential pathway for PPCPs to 
enter the environment  (Heatwole and McCray 2007; Garg and Jha 2005; Hai-long and 
Zu-xin 2006; Connell and Van den Dael 2003; Marshall et al. Jaffe, 2000; USGS 2007). 
However, limited information now exists on the fate of these chemicals in soils and 
ground water from any treatment source, especially from wastewater lagoon systems 
(EPA 2008; USGS 2008b). In order to explore the environmental fate and transport of 
PPCPs, this study considered the topics of pharmacodynamics, wastewater treatment by 
facultative lagoons, ground water hydrology, ground water chemistry and stable isotopes 
for identification of respective PPCPs.  
PPCPs enter wastewater in three primary ways. In urine and feces, humans 
excrete small quantities of the pharmaceuticals they consume (EPA 2008; Drug 
Information Online 2008). While the metabolism of pharmaceuticals varies by individual, 
the principal means of elimination is generally through the urine stream (Hughes 1996; 
Drug Information Online 2008; EPA 2008). Additionally, unused pharmaceuticals enter 
wastewater when flushed into the sewer system, as has commonly been recommended as 
a means of disposal (EPA 2008). Finally, personal care products, such as shampoo and 
soap, enter wastewater when they are washed off any part of the body (EPA 2008). The 
following section describes wastewater treatment processes involving municipal 
wastewater lagoons and land application of treated wastewater, both of which are 
possible sources of PPCPs to the environment. 
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Wastewater Treatment 
Facultative Lagoons 
Wastewater treatment methods impact the amount of and potential for specific 
PPCPs to be present in effluent (EPA 2008; Heberer 2002; Conn et al. 2006; Matamoros 
et al. 2005). PPCPs are organic compounds and to date, limited data exist on the fate of 
PPCPs in facultative lagoons (EPA 2008; EPA 2007b). The most important removal 
pathways of organic compounds during wastewater treatment are: 
biotransformation/biodegradation, adsorption by the sludge (excess sludge removal), and 
stripping by aeration (volatilization) (Richards 1996; Metcalf and Eddy 1991; Qasim 
1999). Lagoons have primarily been studied as a source for nitrogen loading to ground 
water (DeSutter et al. 2005). Knowledge of how facultative lagoons work is fundamental 
for understanding the potential fate of PPCPs in this thesis.  
Facultative lagoons are ponds designed to hold and treat wastewater through a 
combination of physical, biological (aerobic and anaerobic degradation reactions), and 
chemical processes (Figure 2) (EPA 2002; Harris 2003). Each zone has the potential to 
degrade organic compounds, including PPCPs. Lagoons can remove settleable solids, 
biochemical oxygen demand, pathogens, fecal coliform, and ammonia (EPA 2002). 
Lagoons are a treatment system relying on complex biochemistry to degrade organic 
wastes present in wastewater as contained in an earthen berm constructed tank 
environment (EPA 2002; Qasim 1999; Richards 1996; Metcalf and Eddy 1991). 
Detention time allows solids to settle and aerobic, facultative and anaerobic zones are 
created in the ponds (EPA 2002; Qasim 1999; Richards 1996; Metcalf and Eddy 1991). 
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As Figure 2 shows, each of these zones is biologically and physically active and different 
chemical processes treat the wastewater (Harris 2003). 
 
Figure 2 Wastewater Treatment Zones in a Facultative Lagoon (adapted from 
Metcalf and Eddy 1991; Harris 2003) 
Lagoon systems are prevalent in use in the United States (EPA 2002), and there 
are more than 400 lagoon treatment systems in Idaho according to the Idaho Rural Water 
Association (2008). The simple design, operations, and low capital costs make them a 
cost effective wastewater treatment method (Army Corps of Engineers; Muga and 
Mihelcic 2008; Zhang 2001). Compared to mechanical wastewater treatment systems, 
lagoon systems can cost four to five and a half times less (Muga and Mihelcic 2008), 
which makes them a viable option for many communities, and socio-economic 
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considerations. Lagoon systems also have the potential to contribute PPCPs to the 
environment, making this current study of them timely and important. 
Lagoons seep liquids, which percolate into the subsurface. This thesis considers 
wastewater seepage from lagoons as a potential path for PPCPs to enter into the 
environment. Lagoon seepage could provide a major source of PPCPs to enter into the 
environment (see Figure 3). 
 
Figure 3 Lagoon Seepage Into Ground Water (adapted from Dingman 2002; 
Freeze and Cherry 1979) 
The current Idaho Wastewater Rules (IDAPA 58.01.16.493) specify design 
standards for a maximum seepage rate of five hundred gallons per acre per day for new 
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lagoon construction. In contrast to the design standards, the rules also require seepage 
testing to show that existing lagoons constructed after April 21, 2007 seep less than 0.125 
inches (3400 gallons) per acre per day. Existing lagoons constructed before April 21, 
2007 may seep up to 0.250 inches (6800 gallons) per acre per day. Lagoons must be 
tested every ten years for seepage to ensure compliance with the rules. After evaluating 
lagoon seepage testing reports from 2005 through 2008 (DEQ 2009), the results indicated 
that all municipal lagoons tested to date seep to some extent. Lagoons may be designed to 
have minimal seepage, but during the course of use operational and maintenance issues 
(such as membrane punctures, weeds, slope stability, or cleaning) can create conditions 
where seepage occurs or increases (Harris 2003). Nitrates and ammonia are two possible 
drinking water contaminants that can seep from lagoons into ground water. The EPA has 
set maximum contaminants levels (MCL) for nitrates and ammonia in drinking water, 
which in turn limits how much of each parameter may seep from a lagoon. The EPA has 
not, however, established MCLs for the PPCPs under consideration in this thesis, leaving 
PPCPs currently unregulated (EPA 2008; Idaho Department of Administration 2008).  
Wastewater Land Application 
After lagoon treatment, wastewater effluent may still contain PPCPs and, if land 
applied, could contribute additional PPCPs to ground water after percolating through the 
soils. Applying wastewater to land is a way to naturally treat wastewater through soil 
filtration, biological activity, and plant uptake of nutrients; provide aquifer recharge; and, 
eliminate the need for wastewater discharge directly into a surface water body (DEQ 
2007; Heatwole and McCray 2007). Land application of treated wastewater allows for 
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water reuse, as it can provide a source of irrigation water and nutrients for crops (DEQ 
2007; Coppola et al. 2004). A natural treatment system, wastewater land application is 
generally constituent limited (i.e., hydraulics, nutrients, salts, etc) and considers 
agronomic rates of nutrient uptake when crops are grown using the wastewater (DEQ 
2007). Wastewater land application is managed to address where the water travels, its 
surface residence time, its subsurface flow paths, water quality impacts to ground water, 
and the amount of crop cover uptake for both water and its nutrients (DEQ 2007). 
Wastewater land application with a crop system, as seen in Figure 4, is considered a 
treatment system, not a disposal mechanism (DEQ 2007). 
 
Figure 4 Potential Treatment of Wastewater from Land Surface to Ground 
Water (adapted from DEQ 2007) 
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Because land application of wastewater is a treatment system, the additional 
treatment processes may be important when evaluating the PPCP contribution in the land 
applied water. In addition to the typical wastewater processing in the soil layers, there are 
potential PPCP-specific processing mechanisms that are shown in Figure 5.  
 
Figure 5 Potential for PPCPs Treatment in Subsurface (adapted from 
EPA 2008; Hai-long and Zu-xin 2006; Muller et al. 2007; Kummerer 2004) 
The goal is to apply wastewater at a rate and manner that will allow the site-
specific crop system to assimilate the wastewater constituents such that minimal amounts 
will leave the site through leaching or runoff (DEQ 2007). Wastewater land application 
and treatment may be analogous to a controlled precipitation event because the goal is to 
apply wastewater at a rate and manner for optimizing crop uptake of constituents 
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(DEQ 2007). Wastewater land application is a seasonal land use system (DEQ 2007) that 
relies on site-specific design and operation to prevent hydraulic overloading, ground 
water contamination, and impacts to surface water (such as from runoff) at the 
application site (DEQ 2007; Hai-long and Zu-xin 2006). Parameters currently monitored 
at Idaho wastewater re-use sites are site- and system-specific for system design and 
operation and include hydraulic and constituent loading (i.e., nitrogen, total dissolved 
solids, phosphorus, and chemical oxygen demand) (DEQ 2007). The fate and transport of 
PPCPs is not regulated and thus not monitored in wastewater treatment lagoons, 
wastewater reuse sites, or subsequently in the receiving ground water (EPA 2008; Idaho 
Department of Administration 2008). It is now being recognized that, after treatment, 
wastewater still contains trace PPCPs that are biologically active (EPA 2008; USGS 
2002; USGS 2008a; Drewes 2007; Snyder et al. 2004). The fate and transport of these 
emerging contaminants involves a variety of complex processes, and further 
understanding of the potential pathways is needed (EPA 2008; USGS 2002; USGS 
2008a; Snyder et al. 2004).  
Environmental Pathways and Fate of PPCPs in Wastewater 
Throughout the wastewater treatment process, air, water, soil, and biota present 
multiple potential pathways for PPCPs present in wastewater to enter the environment 
(Metcalf and Eddy 1991; Qasim 1999; Richards 1996; Fetter 1999). Three factors 
influence fate and transport of PPCPs: 1) the unique physiochemical properties of PPCPs, 
2) the transport properties of the receiving environment (see Figure 2 and 3), and 
3) chemical transformations of PPCPs along the transport process, which are important in 
13 
 
 
interface dynamics (Domenico and Schwartz 1998; Kinney et al. 2006; Fetter 1999; 
Crosby 1998). In the dynamic and variable environment that PPCPs encounter during 
wastewater treatment, PPCPs partitioning coefficients may be important for predicting 
what will occur during vapor/solid, vapor/liquid, liquid/liquid, or liquid/solid stages in 
treatment and in the environment (Kummerer 2004; Fetter 1999; Crosby 1998). The 
tendency of PPCPs to be in water versus sorbed can provide information about where it 
might exist in the wastewater treatment system. The octanol-water distribution coefficient 
(Kow) will “indicate the tendency of an organic chemical to partition to lipids or fats, sorb 
to particulates such as soils, sorb to biomass or sludge or distribute among the various 
environmental compartments” (Kummerer 2004; Fetter 1999). For example, sorption 
affinity will be influenced by the molecule‟s Kow, its aqueous solubility and its molecular 
structure (Kinney et al. 2006; Kummerer 2004). The less polar a chemical or PPCP is the 
more potential for hydrophobic partitioning to organic matter to occur (Kinney et al. 
2006). The greater the hydrophobicity of the chemical, the greater will be the tendency 
for the PPCPs to partition into the hydrophobic organic phase (Kinney et al. 2006). The 
greater the chemical‟s Kow, the greater will be the tendency for low water solubility, a 
large soil/sediment adsorption coefficient, and a large retardation factor (Kinney et al. 
2006; Lissemore et al. 2006; Kummerer 2004). A flow path relationship has been shown 
to exist with PPCP concentrations (Lissemore et al. 2006). Past studies indicate that 
water-soluble chemicals follow water flow paths and chemicals with high Kow   values 
tend to be found in soils with high total dissolved organic carbon (Lissemore et al. 2006). 
These trends suggest that hydrophilic PPCPs may not attenuate during lagoon treatment. 
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Therefore, understanding a PPCP‟s known chemistry with particular emphasis on Kow 
will provide clues for defining pathways to degradation, sorption, or transport. A sorption 
guide has been proposed (Drewes 2007; Rogers 1996) that refers to a chemical‟s octonal 
water partitioning coefficient where a log Kow less than 2.5 will have low sorption 
potential (Drewes 2007; Rogers 1996). A log Kow between 2.5 and 4 will have medium 
sorption potential and a log Kow greater than 4 will have a high sorption potential 
(Drewes 2007; Rogers 1996).  
In evaluating wastewater treatment systems and PPCPs, the log Kow provides 
predictive evidence for understanding the pathway a PPCP will take, i.e. water or soil 
(sludge). For PPCPs in wastewater, it has been suggested that the concentration 
difference between the influent and effluent provide the clearest indicator of total 
removal efficiency when based upon a mass balance change (Aga 2008). 
PPCP Pharmacodynamics 
Understanding PPCP pharmacodynamics, the reactions between drugs and living 
systems, is needed for proper evaluation of the sampling results. The chosen PPCPs were 
designed to be biologically active chemicals that target end users, so that their direct 
effects, which include their mode of action and side effects, are primarily understood 
(Drug Information Online 2008). The chemistry of the chosen PPCPs is variable and little 
is known about chronic low dose exposure, effects on non-target organisms, and/or 
environmental fate and transport (Aga 2008; Drug Information Online 2008; 
Crosby 1998; Jjemba 2008; Snyder et al. 2004). As a group, a homogeneous set of 
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characteristics both in vivo and in the environment is not expected (Aga 2008; Drug 
Information Online 2008; Crosby 1998; Jjemba 2008; Bateman 2001). Pharmaceutical 
metabolism generally occurs in vivo and involves chemical changes that most often 
convert PPCPs into more readily excreted polar products, thus making them water 
soluble (Kummerer 2004; Jjemba 2008; Bateman 2001; Snyder et al. 2004). In general, 
most drugs are lipophilic chemicals (Nowak 2005) and their metabolites become more 
hydrophilic for elimination (Kummerer 2004; Drug Information Online 2008). This is an 
important characteristic in the discussion on environmental fate and future study needs. 
Another general point is that pharmaceuticals and their metabolites in addition to being 
biologically active are often resistant to degradation. PPCPs may be excreted as the 
original „parent‟ compound, as a conjugate, as metabolite(s) or a combination of the three 
(Aga 2008; Crosby 1998; Kummerer 2004; EPA 2008; Jjemba 2008). The wastewater 
collection system as discussed earlier, collects PPCPs as they are washed off of the body, 
flushed down household drains, or passed out of the body through elimination. The target 
PPCPs for this study are in Table 1 and the following discussion of carbamazepine, 
gemfibrozil, sulfamethoxazole, and estrogens is needed for further understanding of this 
study. 
Table 1 PPCP Physiochemical Properties (adapted from Snyder et al. 2004) 
PPCPs Use 
Molecular 
Weight 
Log 
[Kow] 
Caffeine Stimulant 194.2 -0.07 
Carbamazepine Anti-seizure 236.3 2.45 
Esterone Estrogen 270.4 3.13 
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PPCPs Use 
Molecular 
Weight 
Log 
[Kow] 
Estradiol Estrogen 272.4 4.01 
Ethinyl Estradiol  17 alpha  Synthetic Estrogen 296.4 3.67 
Gemfibrozil Anti-cholesterol 250.3 4.77 
Ibuprofen Analgesic 206.3 3.97 
Iopromide X Ray Contrast 791.1 -2.05 
Progestrone  Estrogen 314.5 3.87 
Sulfamethoxazole  Anti-biotic 253.3 0.89 
Testosterone Androgen 288.4 3.32 
Trimethoprim Anti-biotic 290.3 0.91 
 
Carbamazepine 
Carbamazepine, an anti-psychotic, anti-epileptic, anti-neuralgic, and anti-diuretic 
drug (Drug Information Online 2008; RxList 2009), is one of the most frequently 
detected PPCPs in surface waters and not naturally present in ground water (Clara et al. 
2005; Miao et al. 2005; Metcalfe et al. 2004; Godfrey et al. 2007; Gagne et al. 2006). 
Carbamazepine is a highly polar molecule, (Aga 2008; Daughton 2007; Drewes 2007; Jos 
et al. 2003), about 3% is excreted unchanged in the urine (Daughton 2007; Drewes 2007; 
Jos et al. 2003) and limited studies indicate that less than 10% is removed during sewage 
treatment  (Ternes et al. 2004; Hernando Guil et al. 2007; Miao et al. 2005). 
Carbamazepine has been found in ground water with no degradation shown in travel 
times of more than 6 years (Heberer 2002; Godfrey et al. 2007; Aga 2008; 
Snyder et al. 2004). These characteristics have led to speculation that carbamazepine may 
be considered as an ideal tracer and could serve as an indicator of wastewater seepage 
(Clara et al. 2004; Haack et al. 2009). Ideal tracers are chemicals where there is no 
sorption or reactions that will occur with it in the system of study (Dingman 2002; Trapp 
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and Matthies 1998). Ideal tracers can be a chemical that is present at measureable levels, 
and is not attenuated in the vadose zone or impacted by vegetation (Dingman 2002).  
Sulfamethoxazole  
Sulfamethoxazole is a sulfonamide-based drug. Sulfonamides are generally used 
as antibacterial agents and are the most used class of antimicrobials in the world for 
humans and livestock (Kummerer 2004; Metcalfe et al. 2004). Their mode of action is 
through competitive inhibition of bacterial folate biosynthesis, which is needed for 
nucleic acid synthesis and thus cellular division (Ternes and Joss 2006). This is a process 
that may have important implications to biological (aerobic and anaerobic) degradation 
reactions in facultative lagoons. The overall biodegradation in wastewater treatment may 
be slowed down by antibiotics deactivating the microbial degraders. Since antibiotics are 
included in the wastewater mixtures, there may be plant operation and treatment issues 
that occur as a result of deactivating microbial degraders in treatment (Jjemba 2008). This 
could be important to the discussion of the results if antibiotics are found in the lagoons. 
Additionally, as antibiotic resistant bacteria can be found in wastewater (Volkman et al. 
2004), the antibiotics found in wastewaters may have a potential role in the spread and 
maintenance of multi-resistance of bacterial pathogens (Ternes and Joss 2006; Boreen et 
al. 2004; Gobel et al. 2005). 
Sulfonamides are generally metabolized by acetylation in humans and only about 
15-20% of the active drug appears in the urine (Aga 2008; Ternes and Joss 2006; Gobel 
et al. 2005). Sulfonamide residues are potentially carcinogenetic, and one form, 
sulfamethazine, is a thyroid carcinogen (Metcalfe et al. 2004), necessitating the 
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evaluation of concentrations in wastewaters as an important factor for risk assessment in 
future studies. During wastewater treatment, there is potential for retransformation back 
to the parent compound (Gobel et al. 2007; Gobel et al. 2005). Sulfonamide removal in 
activated sludge and membrane bioreactor (MBR) treatment has been shown to be 
variable but overall incomplete so that it is detectable in the effluent (Karthikeyan and 
Meyer 2006; Gobel et al. 2007). Secondary treatment methods generally reduce 
sulfonamides via sorption and transformation processes (Karthikeyan and Meyer 2006; 
Gobel et al. 2007). Sulfamethoxazole is hydrophilic (refer to Table 1) and the mostly 
commonly detected form in a study looking at sulfonamides (Gobel et al. 2005). 
Sulfamethoxazole has been found in ground water samples (Focazio et al. 2004) and in 
shallow ground water wells hydraulically downgradient from a community septic tank 
drainfield (Godfrey et al. 2007). When considering its environmental fate in a lagoon, a 
study on sulfamethoxazole showed that it may undergo slow photo-degradation in lakes 
(Boreen et al. 2004).  
Gemfibrozil 
Gemfibrozil is an antihyperlipidemic drug that reduces triglycerides and increases 
cholesterol carried in high density lipoprotein (Drug Information Online 2008). 
Gemfibrozil forms metabolites that are eliminated in urine and feces. Six percent of the 
dose can be accounted for in the feces and approximately seventy percent of the 
administered human dose is excreted in the urine, with less than 2% excreted as the 
unchanged parent compound (Drug Information Online 2008). Gemfibrozil has a high 
hydrophobicity (refer to Table 1) and with this tendency to partition into the hydrophobic 
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organic phase, it has also been found in treated effluent from wastewater systems with 
removal efficiencies ranging from 6 to 50% (Quinn et al. 2008; Gagne et al. 2006; 
Daughten and Ternes 1999). Studies also suggest it may be one of the ten most abundant 
PPCPs found in wastewater effluent (Gagne et al. 2006). Studies with gemfibrozil 
indicate a concern for embryonic effects in mammals and that its toxicity rating should be 
reclassified (Quinn et al. 2008). This makes its environmental presence important for 
evaluation.  
Estrogens 
Estrogens occur in males and females during their entire lifetime and have 
different biological effects on the different target tissues (EPA 2008; Raftogianis et al. 
2000; Okayasu et al. 2005). In addition to reproductive organs, estrogens act on the brain, 
bone, liver, and heart (Raftogianis et al. 2000; Okayasu et al. 2005). Estrogens are 
eliminated from the body by conjugation whereby a hydrophilic side chain is attached 
(glucuronic acid or sulfate) making it more soluble to enter the urine stream (Raftogianis 
et al. 2000; Okayasu et al. 2005; Johnson and Williams 2004). Studies suggest that 
de-conjugation can occur through enzymatic hydrolysis in the wastewater collection 
system or treatment process (Drewes 2007; Snyder et al. 2004; Okayasu et al. 2005; 
Johnson and Williams 2004). It is suggested that estrogens have high potential to be 
adsorbed to sewage sludges and that longer solids retention times may result in better 
removal efficiency of estrogens (Drewes 2007). This may be important at the study site 
with a 22 day detention time traveling through the lagoons and an even longer detention 
in the storage lagoon. It has been shown that there is a 60 to 90% removal efficiently of 
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estrogens from wastewater using MBRs and conventional activated sludge wastewater 
treatment methods (Hernando Guil et al. 2007). The bioavailability of estrogens to 
influence the environment makes estrogens an important choice for evaluation in 
wastewaters (Aga 2008; Clara et al. 2005; Conn et al. 2006; Drewes 2007; Snyder et al. 
2004; Daughten and Ternes 1999; Jos et al. 2003; Daughton 2007; Gagne et al. 2006). 
Nitrogen 
Nitrogen is often used as an indicator for fecal contamination of ground water and 
is being studied to determine if there is a correlation between monitoring parameters and 
PPCPs (Jjemba 2008; Haack et al. 2009). As such, there may be a correlation between 
PPCPs and nitrogen transport through the vadose zone and into ground water. Many 
studies have shown that nitrogen transport from surface water sources into ground water 
occurs (EPA 2008; Heatwole and McCray 2007; Garg and Jha 2005; DeSutter et al. 
2005; Haack et al. 2009). Elevated nitrogen concentrations in ground water have been 
implicated with wastewater treatment systems and agricultural operations (Heatwole and 
McCray 2007; Garg and Jha 2005) and shallow aquifers may be vulnerable to nitrate 
contamination (Garg and Jha 2005). Nitrogen removal from this wastewater treatment 
lagoon system may also correlate with some of the chosen PPCPs. If nitrogen is found in 
the ground water with PPCPs, the total removal efficiency of the PPCPs and nitrogen at 
each sampling location can be evaluated.  
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 Oxygen and Deuterium Isotopes 
Isotopes of oxygen and deuterium, a hydrogen isotope, have been shown to 
provide a line of evidence toward establishing hydraulic connectivity, between surface 
water and ground water (Domenico and Schwartz 1998; Freeze and Cherry 1979; 
SAHRA 2005). The fractionation of the stable isotopes of oxygen (
18
O) and deuterium 
(
2
H) in atmospheric water vapor is subject to changes when water evaporates and 
condenses (Domenico and Schwartz 1998; Freeze and Cherry 1979; SAHRA 2005). A 
linear correlation can be inferred as it relates to water that has not undergone evaporation 
(Domenico and Schwartz 1998; Freeze and Cherry 1979; SAHRA 2005). Therefore, 
water with different evaporative histories can have unique isotopic fingerprints 
(Domenico and Schwartz 1998; Freeze and Cherry 1979; SAHRA 2005). Oxygen and 
deuterium ratios can be plotted and compared to the Meteoric Water Line (MWL) (see 
Figure 6), which is the annual average isotope composition of precipitation at locations 
around the globe (Domenico and Schwartz 1998; Freeze and Cherry 1979; SAHRA 
2005). The relationship between 
18
O and 
2
H in meteoric waters is as follows: 
δ2H = 8 δ18O +10‰ (SAHRA 2005). 
Water that has been unaffected by physio-chemical processes (evaporation) 
should fall on the MWL line as it should contain more of the lighter oxygen, as seen in 
Figure 6 (Domenico and Schwartz 1998; Freeze and Cherry 1979; SAHRA 2005).  
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Figure 6 Summary of How Hydrological Processes Affect Oxygen and 
Hydrogen Isotopic Composition of Water (SAHRA 2005) 
As water becomes more depleted in the lighter isotopes through evaporation, it 
will deviate from the MWL (Domenico and Schwartz 1998; Freeze and Cherry 1979; 
SAHRA 2005). The greater the evaporation the farther away the sample will be from the 
MWL (Domenico and Schwartz 1998; Freeze and Cherry 1979; SAHRA 2005). The 
same or similar isotopic signatures suggest hydraulic connectivity between surface water 
sources and ground waters (SAHRA 2005; Coplen et al. 2000). In this study, oxygen and 
deuterium isotope ratios are used to provide evidence to evaluate the connectivity of 
lagoon effluent seepage to ground water (SAHRA 2005; Coplen et al. 2000), because 
wastewater is subject to evaporative processes during its travel time through a lagoon 
(Metcalf and Eddy 1991). The same or similar isotopic signature found in lagoon effluent 
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and ground water may suggest that the effluent, which may contain PPCPs, is recharging 
ground water.  
Study Location  
In order to provide a basis for understanding PPCP contamination contributions 
from wastewater to ground water, a study location was needed that could be searched for 
pharmaceuticals in the environment, and assessed for hydrology with respect to 
movement of pharmaceuticals to the ground water. A specific study site was chosen from 
the Idaho Wastewater Reuse permitted sites list. The chosen study location was the City 
of Mountain Home Idaho due to its wastewater lagoons, existing monitoring wells and 
permitted wastewater land application site. The City of Mountain Home is located in 
Elmore County, in southwestern Idaho (Figure 7).  
The city had a population of 11,143 according to the 2000 census. The population 
has grown to more than 12,500 according to the 2004 estimated census. The 2000 census 
indicated that the population base is distributed in age with 29.6% under the age of 18, 
9.8% between the age of 18-24, 32.8% between the age of 25-44, 18.1% between the age 
of 45-64, and 9.7% over the age of 65. The median age was 32 years (Mountain Home 
Economic Development 2004). This residential population contributes the PPCP loading 
to the wastewater stream.  
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Figure 7 Mountain Home Study Area Showing City of Mountain Home, and 
Wastewater Treatment Facility and Extent of Irrigated Agricultural Area East of 
Wastewater Treatment Facility (adapted from Baldwin et al. 2009) 
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City of Mountain Home Wastewater Treatment 
The wastewater treatment facility is located approximately 2 miles south of the 
city in Elmore County, in sections 1, 2, 11 and 12, Township 4S Range 6E (Keller 
Associates 2006). The location is north of Hamilton Road and is shown in Figure 8. The 
general area land use is open range and agricultural fields, with some rural residential 
surrounding the municipal wastewater treatment site. The site has been permitted by the 
state since 1989 (Idaho DEQ Land Application Permit LA-000037) to land apply its 
treated wastewater (DEQ 1996). The waste streams currently collected are from the 
primarily residential population base; businesses do not contribute any known unusual 
waste and there are no significant industrial discharges to the treatment system (DEQ 
1996). Wastewater treatment consists of a nine cell facultative lagoon system (see Figure 
9) that operates in series.  
The wastewater treatment system was designed for an average daily flow of 1.71 
MGD and a peak hourly flow of 4.9 MGD (DEQ 1996). The lagoons overall occupy 205 
acres with a total volume when full of approximately 406 million gallons (DEQ 1996; 
Keller Associates 2006). The first six clay lined lagoons are treatment lagoons with a 
22 day detention time through the system (Keller Associates 2006; DEQ 2009).The last 
three lagoons store the treated wastewater for up to 214 days during the winter months 
(Keller Associates 2006; DEQ 2009). Storage lagoons seven (7) and eight (8) are clay 
lined on the bottom with membrane liner on the sides and storage lagoon nine (9) is fully 
membrane lined (DEQ 1998; Keller Associates 2006). Storage is followed by disinfection 
using a chlorine solution directly injected into the pipe through a diffuser; treated effluent 
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is then sent to be land applied on 260 acres during the growing season of April 1 through 
October 31 (DEQ 1996; Keller Associates 2006). Irrigation pumps apply effluent by 
sprinkler in accordance with Irrigation Water Requirements throughout the growing 
season to fields that historically were planted with small grain, alfalfa, and sugar beets 
(DEQ 2009; Keller Associates 2006). The permit requires that constituent loading to the 
site for COD is limited to 50 pounds/acre-day for the growing season and the maximum 
nitrogen loading is 150% of crop uptake.  
In 2005, approximately 500 MG of wastewater entered the treatment system and 
286 MG were land applied (Keller Associates 2006). The system was designed for lagoon 
seepage to occur (Keller Associates 2006) and during this study seepage was estimated to 
be 200 million gallons per year (Keller Associates 2006; DEQ 2009). Only eight lagoons 
were in operation during sampling as lagoon six was taken offline in 2002 due to lagoon 
seepage in excess of the state rule limit of 0.250 inches (6800 gallons) per acre per day 
(DEQ 1998). 
The wastewater treatment site has five monitoring wells (MW) and is shown in 
Figure 10. The wells were all drilled to depths of less than 20 feet where basalt rock was 
encountered (Keller Associates 2006; Mountain Home 1991). MW 1, MW 4, and MW 5 
have all been dry as they have never encountered ground water (Mountain Home 1991). 
MW 1 is 20 feet below the ground surface, MW 4 is 12.5 feet below the ground surface, 
and MW 5 is 10.5 below the ground surface (Mountain Home 1991). MW 2 and MW 3 
both have had water present since being drilled, MW 2 is 14 feet deep and MW 3 is 12 
feet deep (Mountain Home 1991). The Mountain Home Land Application site 
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Engineering Reports on file with DEQ and potentiometric contours maps of the regional 
and perched water table show a south to southwesterly direction of ground water flow 
(Figure 11 and 12) (Keller Associates 2006; Arney et al. 1984; Bendixsen 1994; Shervais 
et al. 2002; DEQ 2009; Young et al. 1992). The contours support that MW 1 is 
upgradient from the lagoons; MW 2 and MW 3 are downgradient from the lagoons and 
upgradient of MW 4 and MW 5 (Figure 10). 
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Figure 8 Mountain Home South Study Area with Township, Range and Section 
Overlay Showing City of Mountain Home Wastewater Treatment Lagoons (adapted 
from Baldwin et al. 2009) 
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Figure 9 City of Mountain Home Wastewater Treatment Facility Lagoons 
(adapted from Google Earth 2007) 
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Figure 10  Monitoring Wells at Mountain Home Wastewater Treatment Facility 
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Figure 11  Potentiometric Contours on the Regional Water Table, Mountain 
Home Area (adapted from Young et al. 1992); Black Outline Shows General 
Location of Mountain Home Wastewater Treatment Facility (adapted from Baldwin 
et al. 2009) 
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Figure 12  Potentiometric Contours on the Perched Water Table, Mountain 
Home Area (adapted from Young et al. 1992); Black Outline Shows General 
Location of Mountain Home Wastewater Treatment Facility (adapted from Baldwin 
et al. 2009)  
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Geology 
The City of Mountain Home and the wastewater treatment site are on a southwest 
sloping broad flat plateau that lies at an elevation of about 3,140 feet above mean sea 
level on the northeast margin of the western Snake River Plain as shown in Figure 13 
(Shervais et al. 2002; Arney et al. 1984).  
 
Figure 13 Regional Map of the Western Snake River Plain Showing Mountain 
Home, the Danskin Mountains to the North and the Mount Bennett Hills to the 
Northeast (original source Shervais et al. 2002 and adaption taken from Baldwin et 
al. 2009) 
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The geological framework of the area provides a context for recharge to the local 
and regional aquifer system (Baldwin et al. 2009). Rhyolite lavas from volcanic activity 
form the base layer on which sediments and basalts were deposited (Shervais et al. 2002) 
(Figure 14).  
 
Figure 14  Interpretative Cross Section Across the Western Snake River Plain in 
the Vicinity of Mountain Home; Line of Section A-A’ is Shown on Figure 13 
(original source Shervais t al. 2002 and adaption taken from Baldwin et al. 2009) 
Shield volcanoes located southwest of Mountain home created a basalt cap over 
underlying sediments (Shervais et al. 2002; Wood and Clemens 2002). This basalt cap, 
represented by QTrs on Figure 15, surrounds a topographic low that includes the City of 
Mountain Home and the wastewater treatment site (Baldwin et al. 2009).  
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Figure 15 Geologic Map and Explanation of Units for the Mountain Home Area 
Prepared by Shervais et al. 2002 (original source Shervais et al. 2002 and adaption 
taken from Baldwin et al. 2009) 
Well drillers logs from wells located south of Mountain Home show that the 
uppermost basalt is from about 460 to 540 feet thick and is overlain by deposits of clay, 
36 
 
 
silt, sand and gravel, referred to as Quaternary Alluvium (Qal) on the map (Baldwin et al. 
2009). The thickness of the alluvium (ranging up to about 80 feet) reveals the relief of the 
underlying basalt surface (Baldwin et al. 2009) and was determined from drillers‟ logs for 
wells located within the outline of the alluvial deposits as shown in Figure 16 (Baldwin et 
al. 2009).  
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Figure 16  Map Showing Outline of Qal in the Mountain Home Area and 
Alluvium Thickness, in Feet, from Selected Wells (original source Shervais et al. 
2002 and adaption taken from Baldwin et al. 2009) 
This area forms the moat where the perched aquifer exists surrounded by basalt 
(Shervais et al. 2002; Baldwin et al. 2009). A cross-sectional area of the Qal formation in 
Figure 17 shows alluvial material that lies over the basalt.  
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Figure 17  Cross Sectional Area of Study Site (derived from Baldwin et al. 2009) 
Ground water 
A shallow perched aquifer and a deep regional aquifer exist in this study area 
(Norton et al. 1982; Bendixsen 1994; Baldwin et al. 2009). The localized perched aquifer 
is within the shallow alluvial material mentioned above with the potentiometric contours 
previously shown in Figure 12. This area underlies about 38,000 acres (Young et al. 
1992) that includes the wastewater treatment site area. This aquifer has a depth to ground 
water of 2 to 40 feet within the shallow sediments and is found mainly in the clay, silt, 
sand, and gravel of the Quaternary Alluvium (Qal) (Norton et al. 1982). Recharge to the 
perched aquifer occurs from local creeks, irrigation canals, and a reservoir located north 
of the study area (Norton et al. 1982; Bendixsen 1994; Baldwin et al. 2009). Seepage 
from the wastewater treatment lagoons also provides some recharge to the perched 
aquifer (Norton et al. 1982; Bendixsen 1994). Ground water contour maps from multiple 
studies of the area between 1968 and 1990 indicate that the direction of ground water 
movement in the perched aquifer is towards the southwest (Norton et al. 1982; Keller 
Associates 2006; DEQ 2009; Bendixsen 1994; Young et al. 1992), which includes the 
39 
 
 
area at the wastewater treatment site as seen in Figure 12. An evaluation of data sets and 
elevation contours for this perched aquifer from studies from 1968 to 1990 indicates that 
no significant changes to flow direction or gradient have occurred over this time 
(Bendixsen 1994). It is assumed that the sources of recharge water and the discharge area 
remain similar to the conditions from 1968 to 1990. This area according to IDWR was 
targeted for further hydrological study and due to budget constraints action toward the 
study is on hold.  
Depth to ground water in the deeper regional aquifer is from 200 to 400 feet 
below land surface. The water is found primarily in basalts and poorly consolidated 
detrital material (Norton et al. 1982; Bendixsen 1994; Baldwin et al. 2009; Young et al. 
1992). The regional aquifer has permeable zones of highly fractured basalt that occur 
within dense, relatively impermeable flow units. Recharge to the regional aquifer occurs 
through precipitation in the mountains north of Mountain Home, percolation from 
ephemeral streams on the plateau, and through percolation from the perched aquifer 
(Norton et al. 1982; Bendixsen 1994). Ground water flow in the regional aquifer is in a 
south to southwest direction (Norton et al. 1982; Keller Associates 2006) as shown in 
Figure 11. 
Conceptual Model 
In order to evaluate the potential migration of the wastewater into the perched 
aquifer a conceptual model of the underlying ground water flow regime is necessary. The 
geological formations in the study area provide a context for discussion of the 
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hydrogeologic conditions present at this site and are needed to develop a qualitative 
conceptual model of ground water flow paths. Further, several historic studies of ground 
water flow within the area are discussed.  
Model Boundaries 
The hydrogeologic conditions of the site combined with several dry wells around 
the periphery of the perched aquifer establish boundary conditions where ground water is 
not present. As a consequence, boundary conditions can be clearly defined to establish 
ground water flow paths within the perched aquifer on a qualitative basis. A one box 
model as outlined in Figure 18 was chosen, as there is not enough available quantitative 
information to apply an analytical solution for contaminant transport (such as the 
Domenico and Schwartz model) (Schnoor 1996). The goal of the conceptual model is to 
describe in some qualitative manner flow characteristics and associated ground water 
flow paths in the perched aquifer.  
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Figure 18 Aerial View of One Box Model of Site System Boundary 
The boundaries of the model have been chosen to correspond with known 
boundary conditions where possible. Water flow in and out of the model boundaries is 
used to characterize flow within the one box model. A three-dimensional box of the 
boundaries is shown in Figure 19. 
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Figure 19 Perspective View of Site System  
The boundaries are described below. 
Northerly No Flux Boundary 
The northerly no flux boundary is a flow line that is dictated by the Potentiometric 
Contours on the Perched Water Table, Mountain Home Area (Figure 12). The northerly 
no flux boundary is a physical boundary associated with flow paths and extends through 
Monitoring Well 1 where no ground water is present and follows the south west flow 
path of the perched aquifer to the extent of the perched aquifer (Figure 18 and 19). This 
boundary extends vertically from the ground surface approximately 20 feet to the basalt 
cap. Dry wells, which extend to the basalt layer underlying the perched aquifer, lie along 
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this boundary. As a consequence, it is assumed that no ground water flows across this 
boundary.  
Southerly No Flux Boundary 
The southerly no flux boundary is a flow line that is dictated by the 
Potentiometric Contours on the Perched Water Table, Mountain Home Area (Figure 12). 
The southerly no flux boundary is a physical boundary associated with flow paths and 
extends through Monitoring Well 4 (Figure 10), where no ground water is present and 
follows the south west flow path of the perched aquifer to the extent of the perched 
aquifer (Figure 18 and 19). This boundary extends vertically approximately 10 feet from 
the ground surface to the basalt cap. As a consequence, no ground water flows in the 
alluvium of the perched aquifer across this boundary. 
Up gradient In-Flux Boundary 
The eastern boundary extends horizontally from the eastern edge of the northern 
boundary to the eastern edge of the southern boundary (Figure 19). Based upon the large 
scale ground water gradients, of approximately 60 ft per mile (Young et al. 1992), ground 
water flows into the perched aquifer of the conceptual model along this boundary.  
Downgradient Boundary 
The downgradient boundary (Figure 18 and19) exists to the western edge of the 
alluvial deposits and thus the western extent of the perched aquifer (Shervais et al. 2002; 
Baldwin et al. 2009). It extends horizontally from the western edge of the northern no 
flux boundary to the western edge of the southern no flux boundary. This downgradient 
boundary extends from the ground surface to the basalt cap. As a consequence of the 
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alluvium material deposition ending, there is no ground water present as the alluvium of 
the perched aquifer does not exist along this boundary. It is assumed that no flow exists 
across this boundary. 
Lower Boundary 
The lower boundary is defined by the basalt cap underlying the perched aquifer 
(Figure 20). At the western edge of this boundary, the basalt cap rises to the surface and 
the alluvial sediment ends (Shervais et al. 2002; Baldwin et al. 2009). Based on this 
information, it is assumed that flows through this boundary, if present, are downward 
under the influence of gravity since it is not under confining conditions. 
Upper Boundary 
The upper boundary is defined by the ground surface as shown in Figure 20.  
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Figure 20 Flow Paths Through System  
Excluding wells, water crossing this boundary is from evaporation, precipitation, 
lagoon seepage, and land applied wastewater. As discussed earlier, the 205 acres of 
lagoons seep approximately 200 million gallons per year into the alluvium of the perched 
aquifer. This represents a defined inflow into the conceptual model.  
Flow Paths 
The flow paths across the boundaries of the conceptual model characterize the 
flow paths for water and PPCPs (Figure 20). Water flowing into the system could be from 
precipitation, the upgradient perched aquifer, and the headworks. Water flowing out with 
PPCPs could go to the downgradient perched aquifer (through the sludge of the lagoon), 
be applied on the land application site, and flow from the perched aquifer into the basalt 
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layer. Based upon the descriptions of the boundary conditions that are defined in the 
conceptual model, MW 2 exists within the perched aquifer downgradient of seepage from 
the lagoons. Based upon the descriptions of the boundary conditions that are defined in 
the conceptual model, MW 3 is not downgradient of the lagoons. The conceptual model 
and flow paths indicate that MW 2 has the potential to be impacted by PPCPs from the 
lagoon if PPCPs exist in the perched aquifer. The conceptual model and flow paths 
indicate that MW 3 exists in the perched aquifer but should not be impacted by any 
PPCPs originating from the lagoons.  
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MATERIALS AND METHODS 
In this section, the general approach to determine if PPCPs can be contributed to 
ground water at the City of Mountain Home Municipal Wastewater Lagoon Treatment 
site will be discussed. This provides a basis for understanding PPCP contamination 
contributions from wastewater to ground water at the study site.  
Local studies on the issue of PPCPs must focus on reconnaissance, which 
includes collection of baseline data examining PPCP use patterns and related population 
densities (Focazio et al. 2004). As studies of specific wastewater sites grow, the data may 
expose relevant trends in PPCP fate and transport over the range of wastewater treatment 
and hydrologic conditions across the United States. Concentration differences of PPCPs 
found at this study site in the influent (the headworks) and the effluent (storage lagoon) 
were evaluated for total removal efficiency. Additionally, concentration differences of 
PPCPs found in ground water at monitoring wells at this study site were evaluated for 
total removal efficiency. 
Sampling Parameters 
The sampling parameters will be discussed, followed by the sampling methods. 
The target PPCPs for this study are in Table 1 and were chosen based upon analytical 
capabilities, costs, occurrence data from previous studies (Aga 2008; Clara et al. 2005; 
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Conn et al. 2006; Drewes 2007; Snyder et al. 2004; Daughten and Ternes 1999; Jos et al. 
2003; Daughton 2007), and physio-chemical properties.  
The target list includes primarily pharmaceuticals and was initially limited to 
evaluating carbamazepine, gemfibrozil, sulfamethoxazole, and the estrogens 
Progesterone, Esterone, Estradiol, and Ethinyl Estradiol 17alpha. Upon evaluation of 
analytical laboratories capable of testing for these parameters, the list was expanded to 
include twelve that were part of an analytical panel offered by the chosen lab. The 
remaining PPCPs were only evaluated for presence or absence in analytical results.  
Carbamazepine 
Carbamazepine was reviewed to determine its flow through the system and 
potential as an indicator PPCP. It is unknown if the demographics of the area around the 
Mountain Home site are such that carbamazepine is used enough to be detectable in the 
headworks; however, it was chosen due its detection in other studies and low octanol-
water partitioning coefficient. 
Sulfamethoxazole  
Because studies have shown that sulfamethoxazole may be degraded in lakes, it 
may be correlated to the storage lagoon water at this site. Based upon the limited 
analytical data and the variance of fate and transport data, it was unknown if 
sulfamethoxazole could be found in the treatment system or the ground water system in 
the study area. The prevalence of its use worldwide suggested that it could be found in 
the headworks if there was enough used in this community. 
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Gemfibrozil  
Since gemfibrozil has a high hydrophobicity and is found frequently in 
wastewater effluent, it was chosen as a sampling parameter. It is unknown if gemfibrozil 
will be detectable from this small population in the headworks. If it is present in the 
headworks, the high hydrophobicity suggests that it may just go directly into the sludge.  
Estrogens  
Based upon the incomplete removal efficiency of estrogens reported, there is the 
potential to find estrogens in the headworks and discharge effluent at this site. Four 
estrogens were tested for in the samples; Progesterone, Esterone, Estradiol, and Ethinyl 
Estradiol 17alpha (refer to Table 1). Each has a hydrophobicity, which influences a 
tendency to partition into the hydrophobic organic phase, which suggests presence in the 
sludge. 
Isotopes in Wastewater Treatment Lagoons 
The wastewater lagoon treatment is subject to evaporative processes during the 
time it takes for water to travel through the series of nine lagoons, and as it remains in the 
ponds for winter storage. Ground water within the site boundary impacted by the lagoons 
should contain water with a similar isotopic signature as the lagoons, or be representative 
of water that was mixed with evaporative water from the lagoons (Baldwin and Cook 
2004; Baldwin et al. 2009). The oxygen and deuterium isotope results may provide 
evidence for hydraulic connectivity between surface and ground water based on 
evaporation (Crosby 1998; Baldwin and Cook 2004; Schnoor 1996; Baldwin et al. 2009). 
It is expected that the ground water in the regional aquifer would not have been exposed 
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to evaporative processes and that the headworks for the wastewater treatment system 
water would have an isotopic signature similar to the regional aquifer since the regional 
aquifer is the source of water to the city and thus to the wastewater treatment collection 
system (Baldwin et al. 2009). It is also expected that if water from the lagoons 
contributes to the perched aquifer, the perched aquifer should have an isotopic signature 
similar to lagoon water (Baldwin and Cook 2004; Baldwin et al. 2009). A public water 
system (PWS) well upgradient of the lagoon system was sampled. Water from this well 
should be similar in isotopic signature to the water in the headworks since evaporative 
processes are limited as water travels from the well to the wastewater treatment site.  
Sampling Methods 
Based upon expectation of flow paths (Figure 20), four sampling locations were 
chosen to be sampled in series from the site that is assumed to have the least potential of 
PPCPs to the site that had the greatest potential for high concentrations of PPCPs. Grab 
water samples were taken November 2007, following the experimental plan as follows. 
Samples were taken from Monitoring Well 2, then Monitoring Well 3. Afterward, 
samples of wastewater were collected from the last wastewater lagoon in series and then 
near the headworks or influent to the first lagoon. 
All personnel on the water sampling team reviewed procedures for using EPA 
Method 1669 (i.e., “clean hands/dirty hands” procedures) for Sampling Ambient Water 
for Trace Metals. This protocol was modified for sampling trace PPCPs with appropriate 
considerations for the ability to contaminant water samples with the PPCPs of interest. 
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The intent is to maximize the ability of the field sampling team to collect samples reliably 
and eliminate sample contamination. The collection of samples included a duplicate and 
field blank for the first four samples taken. The duplicate consisted of sample containers 
filled with the same composite water from the same sampling site. The duplicates 
determine both field and laboratory precision. The field blank sample was used to 
determine the integrity of the field sampling events, the condition of the sample 
containers supplied by the laboratory, and the accuracy of the laboratory methods. Both 
the duplicates and blank samples are stored and handled with the normal sample load for 
shipment to the laboratory. MWH Laboratories (Table 2) was used for PPCP sample 
testing as it met the Unregulated Contaminant Monitoring Regulations (UCMR) 
Laboratory Approval Program application and Proficiency Testing (PT) criteria. MWH 
Laboratories is an EPA Approved laboratory for sampling UCMR using EPA 527, 529, 
521, 525.2, and 535 methods for PPCP analysis. 
Table 2 Laboratories 
Laboratory List Parameters Address  
Idaho Bureau of 
Laboratories 
TKN, NH4, NO3-N, Cl, 
SO4, TDS, Total P 
2220 Old Penitentiary Rd 
Boise ID 83712 
U of Arizona 
Environmental Isotope 
Laboratory 
Isotopes: 
18
O, D, 
15
N  
Dept. of Geosciences 
Tucson, AZ 852721-0077 
MWH Laboratories PPCPs 
750 Royal Oaks Dr, Ste 
100, Monrovia, CA 
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The laboratory used for testing of general field parameters is the Idaho Bureau of 
Laboratories (Table 2), which is certified for the chemical and microbiological testing of 
drinking water from public water systems as part of the primacy agreement between the 
State of Idaho and EPA.  It is certified for microbiological, organic chemistry, and 
inorganic chemistry analytes and methods. 
The laboratory used for isotopes was the University of Arizona Environmental 
Isotope Laboratory (Table 2). This laboratory has been used for isotope testing previously 
for some of the sample sites and was used for consistency of sample and data evaluation.  
At each well, a Geopump Peristaltic Pump was used to draw samples from the 
wells. Field parameters for specific conductance, pH, temperature, and total dissolved 
solids were measured with a Horiba Water Quality Checker U-10. The pH and 
conductivity meters were calibrated to manufacturer specifications, then measurements 
taken from each well while purging. Field parameter measurements were considered 
stable when three successive measurements taken at intervals of 5 minutes or more 
differed by the following:  specific conductance 5% or less, pH 0.1 unit or less, and 
temperature 0.2 ºC or less. 
Prior to donning personal protective equipment and obtaining any sample, field 
personnel designated roles and responsibilities for the sampling and discussed the 
modified procedures that needed to be used during sampling events. Care was taken not 
to spill any contaminants (e.g., water, etc.) on or near the sampling site, or to let any 
sampling equipment come into contact with potential contaminants. Field personnel wore 
powder-less nitrile laboratory gloves during sampling and processing and changed to 
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clean gloves with each change in activity or potential glove contamination. They avoided 
breathing directly over open samples/equipment and avoided direct contact between 
themselves (including clothing) and the sample, sampling device, and processing 
equipment. On the day of sampling activities, they avoided contact with or consumption 
of the products listed below: 
 Wastewater compounds such as soaps and detergents, including antibacterial 
cleansers.  
 Pharmaceutical compounds such as prescription drugs, medications, and 
hormonal substances that are in the list of PPCPs.  
Upon arrival at the sampling sites, one member of the two person sampling team was 
designated as “dirty hands” and the other “clean hands.” The persons assumed the “dirty 
hands” and “clean hands” roles wearing Tyvek coveralls and powder-less nitrile 
laboratory gloves, and surgical masks with sampling equipment and containers 
appropriately staged nearby. The dirty hands sampler observed techniques employed by 
clean hands personnel and to notify the field team immediately in the event that any 
possible contamination was observed or suspected, or if incorrect sampling techniques 
were utilized.  
The clean hands sampler touched the sample container and transferred the sample 
from the sample collection device to the sample container. The dirty hands sampler was 
responsible for the operation of the machinery and other activities that did not involve 
direct contact with the sample. “Clean hands” placed the clean empty sample containers, 
removed the lids of the containers, and placed the end of the tubing into the containers. 
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“Dirty hands” started the pump. “Clean hands” moved the tubing to a clean container. 
“Dirty hands” stopped the pump. “Clean hands” replaced the lid on the container and 
returned the container to the designated place. “Dirty hands” placed the bottle into the 
cooler. Gloves were changed between samples and sample sites. Samples were collected 
as quickly as is reasonably possible, while carefully preventing any contact between the 
containers and any surface other than the sampling surface. Lagoon samples were 
collected by using a grab sampling technique, through immersion into the water by a 
certified clean amber glass bottle and transferring that into the laboratory prepared 
bottles. The water in the monitoring well samples was pumped to the surface and the 
sample containers filled directly. Collected samples were stored in ice chests with freezer 
packs to maintain 4
o
C from the time of the sampling event until sample custody was 
transferred to the lab. After leaving the field, samples going to MWH laboratory were 
packed for shipment and sealed in ice chests with refrigerated packs, with the required 
chain of custody forms. Samples going to Idaho Bureau of Laboratories were dropped off 
by field personnel and samples going to U of Arizona Environmental Isotope Laboratory 
were shipped. 
Some additional isotopes were collected May 2008 from the lagoons for additional 
verification of isotopic evidence. Laboratories analyzed samples as shown in Table 3. 
The sample containers were provided by the laboratories in order to ensure that they were 
clean, uncontaminated, and suitable for the analysis methods used (Table 4). 
The details are further described in the Quality Assurance Plan (QAPP) that is found 
in Appendix A and is included within this thesis. The QAPP was based on the EPA 
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guideline methods available at the time of the original sampling (EPA 2007a; EPA 
2007c). The purpose of the QAPP was to ensure that the sample collection and testing 
was performed appropriately. As fieldwork was conducted, the QAPP document was 
referenced to maximize the ability of the field sampling team to collect samples reliably 
and eliminate sample contamination.  
Table 3 Laboratory Analysis Method 
Parameters Test Method Lab 
Caffeine USGS 2 mod MWH Laboratories 
Carbamazepine USGS 2 mod MWH Laboratories 
Esterone USGS 2 mod MWH Laboratories 
Esteradiol  USGS 2 mod MWH Laboratories 
Ethinyl Estradiol  USGS 2 mod MWH Laboratories 
Gemfibrozil  USGS 2 mod MWH Laboratories 
Ibuprofen USGS 2 mod MWH Laboratories 
Iopromide USGS 2 mod MWH Laboratories 
Progestrone  USGS 2 mod MWH Laboratories 
Sulfamethoxazole  USGS 2 mod MWH Laboratories 
Testosterone USGS 2 mod MWH Laboratories 
Trimethoprim USGS 2 mod MWH Laboratories 
δ18O% IRMS University of Arizona  
δD% IRMS University of Arizona  
Total Kjeldahl Nitrogen, 
TKN 
SM 4500-Norg D Idaho Bureau of Laboratories 
Ammonia as N SM 4500 NH3 H. Idaho Bureau of Laboratories 
Nitrogen, Nitrate+Nitrite EPA 353.2 Idaho Bureau of Laboratories 
Chloride EPA 300.0 Idaho Bureau of Laboratories 
Sulfate EPA 300.0 Idaho Bureau of Laboratories 
Total Dissolved Solids SM 2540C Idaho Bureau of Laboratories 
Total Phosphorus 10-115-01-1-F Idaho Bureau of Laboratories 
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Table 4 Sampling Locations and Containers Used 
Sample Location 
Idaho Bureau of 
Laboratories 
U of Arizona 
Environmental 
Isotope 
Laboratory 
MWH Labs 
Well H2O Monitoring Well 2 
2 1-liter 
Polyethylene 
Cubitainers 
1 125 mL 
Polyethylene 
Container 
Collect 3 
Samples:  1 
Liter Glass 
Amber 
Bottles 
Well H2O Monitoring Well 3 
2 1-liter 
Polyethylene 
Cubitainers 
1 125 mL 
Polyethylene 
Container 
Collect 3 
Samples:  1 
Liter Glass 
Amber 
Bottles 
Effluent H2O WW Lagoon 8 
2 1-liter 
Polyethylene 
Cubitainers 
1 125 mL 
Polyethylene 
Container 
Collect 3 
Samples:  1 
Liter Glass 
Amber 
Bottles 
Influent H2O 
Headworks/Lagoon 
1 
2 1-liter 
Polyethylene 
Cubitainers 
1 125 mL 
Polyethylene 
Container 
Collect 3 
Samples:  1 
Liter Glass 
Amber 
Bottles 
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RESULTS AND DISCUSSION  
PPCPs were detected in the samples from the headworks, in the storage lagoon 
and in a monitoring well downgradient of the lagoon. Twelve PPCPs were tested and 
eleven were found in the headworks. Seven PPCPs were found in the storage lagoon. Six 
PPCPs were found in downgradient MW 2. Water isotopes from these samples were 
examined to further evaluate flow paths.  
The sampling results indicate detection of PPCPs in both wastewater and ground 
water and a summary of the data from the sampling events are found in Table 5, 6, and 7. 
The raw data can be found in Appendix B. The results indicate that PPCPs are present in 
detectable and varying concentrations in the samples. 
The QAPP defined guidelines for differences within duplicate samples and 
allowed concentrations in field blanks. These guidelines, when met, provide a measure of 
accuracy, consistency, and validity of the test results. The results were compared with the 
QAPP guidelines. Per the QAPP, duplicate samples should be within 30% of each other 
in order to be valid. All samples, except Caffeine and Esterone, complied with the 
maximum relative standard difference of 30% as specified in the QAPP. Further 
discussion of Estrogen related compounds are presented in a section specific to these 
compounds. Additionally, the QAPP specifies all field blank samples should contain 
below acceptable values for PPCPs. The field blank samples, except Caffeine, were no-
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detect and thus fall within the guidelines specified within the QAPP. As a consequence of 
the above analysis, all PPCPs test results, except for those of Caffeine and Esterone, are 
considered accurate. 
The PPCP data and isotopic data for all samples will now be discussed to provide 
a more complete picture of the results. Where connectivity is present between the lagoons 
and monitoring wells, PPCP concentrations are evaluated for total removal efficiency.  
Table 5 Results for Field Parameters and Major Ions from November 2007 
Sampling Event 
  
  
Parameters 
  
Units 
Sample Location 
PWS 
Well 
Headworks 
Lagoon 
8 
MW 2 MW 3 
F
ie
ld
 
P
a
ra
m
et
er
s 
Temp (deg C) 18.6 
  
12.5 14.8 
pH (units) 8.6 
  
6.93 7.24 
Sp Cond (uS/cm) 401 
  
1100 750 
D.O. (mg/L) 
   
0.07 2.67 
turbidity NTU 
   
0 0 
M
a
jo
r 
Io
n
s 
Ammonia 
as N 
(mg/L) 0.01 19 8.1 0.03 0.01 
Cl (mg/L) 16 33.5 67.8 101 31.70 
Nitrogen, 
Nitrate-
Nitrite 
(mg/L) 2.5 0.27 0.58 <0.01 6.00 
Nitrogen, 
Total 
Kjeldahl 
(mg/L) 0.2 27 14 0.62 0.30 
Total 
Nitrogen 
(mg/L) 2.7 27.27 14.58 0.63 6.3 
Total 
Phosphorus 
(mg/L) 0.02 3.8 4 0.13 0.27 
Sulfate (mg/L) 42 22.7 46.9 19.7 111.0 
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Parameters 
  
Units 
Sample Location 
PWS 
Well 
Headworks 
Lagoon 
8 
MW 2 MW 3 
Total 
Dissolved 
Solids 
(mg/L) 260 269 516 673 523.0 
 
 
 
 
Table 6 Results for PPCPs from November 2007 Sampling Event 
    Sample Location   
PPCP 
Detect 
Limit 
PWS 
Well 
Headworks 
Lagoon 
8 
MW2 
MW2 
duplicate 
MW 
3 
Field 
Transfer 
ng/L 
Caffeine 5 ND 7920 48 12 36 2.6 ND 
Carbamazepine 5 ND 92 64 77 82 ND ND 
Esterone 1 ND 16 450 120 ND ND ND 
Estradiol 1 ND ND 49 ND ND ND ND 
Ethinyl Estradiol  
17 alpha  
5 ND ND 62 9 ND ND ND 
Gemfibrozil  1 ND 440 880 ND ND ND ND 
Ibuprofen 1 ND 1820 ND ND ND ND ND 
Iopromide 5 ND 17 ND 6.8 ND ND ND 
Progestrone  1 ND 520 ND ND ND ND ND 
Sulfamethoxazole  1 ND 158 87 1.1 5.8 ND ND 
Testosterone 1 ND ND ND ND ND ND ND 
Trimethoprim 1 ND 40 ND ND ND ND ND 
ND:  Non Detect 
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Table 7 Isotope Data 
Location Sample Date δ18O% δD% 
(per mil) (per mil) 
PWS well Nov-07 -15.5 -124 
Headworks Nov-07 -16.0 -124 
Lagoon 8 Nov-07 -7.0 -79 
MW-2 Nov-07 -7.6 -83 
MW 3 Nov-07 -14.5 -116 
Lagoon 7 May-08 -1.5 -56 
Lagoon 4 May-08 -8.7 -93 
Lagoon 3 May-08 -9.9 -99 
Lagoon 2 May-08 -11.3 -106 
Lagoon 2 May-08 -11.3 -106 
Headworks May-08 -15.9 -125 
 
Isotopes 
Isotope data of oxygen and hydrogen (
18
O and 
2
H) are listed in Table 7 and 
plotted in Figure 21. The data show an evaporative trend from the headworks through the 
series of lagoons.  
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Figure 21  Oxygen Versus Deuterium Isotopes for Samples Collected, Plotted 
Against the MWL 
The headworks and PWS have comparable isotopic values. This confirms that the 
water from the regional aquifer has undergone little evaporation as it travels from the 
well head through the distribution system and to the wastewater treatment system. The 
samples from wastewater treatment lagoons 2, 3, and 4 show a progressive increase in 
concentration of the heavier isotopes of oxygen and deuterium. This indicates that the 
water in the lagoons has evaporated as it has passed through the successive lagoons as 
more 
16
O and 
1
H has entered the vapor phase. The storage lagoons contain treated water 
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that is entering for storage, and water that has been accumulating in the lagoon for 
storage over the winter (or non-irrigation season). The water samples collected from 
these lagoons show additional evaporative effects and plot in the upper-right part of the 
graph. The range in oxygen and deuterium values reflects evaporative effects of 
seasonality and detention time. The storage lagoons are designed so that Lagoon 7 is 
filled first and then drawn down last, as water is pumped for irrigation in the summer. 
The isotopic evidence also supports this as shown in Figure 21. The results show that the 
most evaporation has occurred in Lagoon 7, which has the longer detention time. Lagoon 
9 should be the last to fill and the first to empty in the series of three storage lagoons, thus 
it will have the shortest detention time for all three storage lagoons. The data confirms 
that lagoon 9 has less evaporative effects than lagoon 7 and 8. MW 2 also shows 
evaporative effects indicative of surface water from lagoon 9. MW 2 is downgradient of 
lagoon 9, and isotope results from the lagoon water and the ground water at MW 2 are 
similar. The isotope evidence indicates that ground water at MW 3 does not contain water 
that has been exposed to evaporative effects to the same extent as the wastewater 
treatment and storage lagoons. This is a line of evidence for establishing that the water 
from MW 3 is not hydraulically connected to water seeping from the pond system. These 
isotopic data corroborate the ground water flow direction derived from measurement of 
ground water level in the perched aquifer (shown in Figure 12) and show that ground 
water cannot flow from MW 2 to MW 3. The isotopic results from MW 3 indicate that 
ground water at this well is primarily from sources that are not lagoon surface water. 
Thus, the ground water flow direction in the perched aquifer is to the west or southwest 
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from the lagoons and MW 3 is cross gradient to ground water originating from the lagoon 
system. This isotope data is in agreement with conceptual model. 
Carbamazepine 
Carbamazepine data (Table 8) represented in the column chart shown in Figure 22 
indicates that carbamazepine was found in six sampling locations, including MW 2 in the 
perched aquifer.  
Table 8  Carbamazepine Concentrations from Collected Samples 
Analyte 
PWS Headworks 
Lagoon 
8 
MW 
2 
MW 2 
duplicate 
MW 
3 
Field 
Transfer 
ng/L ng/L ng/L ng/L ng/L ng/L ng/L 
 
Carbamazepine 
ND 92 64 77 82 ND ND 
 
 
Figure 22  Carbamazepine Concentrations from Collected Samples 
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The average concentration found from all six samples taken was 79.2 ng/L. The 
carbamazepine concentrations show comparable values (an average of 78  ng/L) through 
the wastewater treatment process from the headworks to lagoon eight. The total removal 
efficiency of the wastewater treatment system indicates approximately 30% treatment 
removal of carbamazepine from the headworks to the storage lagoon. The data from the 
samples taken from MW 2 indicate an average concentration of 79.5 ng/L. The isotopes 
and the carbamazepine data indicate that the lagoon water is impacting the local perched 
aquifer at MW 2. These findings support that carbamazepine shows little attenuation 
during ground water recharge. The log [Kow] of carbamazepine (Table 1) is less than 2.5, 
which, as discussed earlier, would be predictive of having low sorption potential. This 
data supports the premise that carbamazepine sorption is very low. These findings may 
also support that carbamazepine can be used as an indicator parameter, to identify and 
perhaps quantify domestic waste impact to ground water. 
There was no detection of carbamazepine in the blank water field transfer and 
MW 3. The carbamazepine data along with the isotope data further suggests that MW 3 is 
not downgradient to the lagoon system, and is in agreement with conceptual model.  
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Sulfamethoxazole 
Sulfamethoxazole data (Table 9) represented in the column chart shown in Figure 
23 indicates that sulfamethoxazole was found in the headworks, the storage lagoon, and 
MW 2 in the perched aquifer. 
Table 9  Sulfamethoxazole Concentrations from Collected Samples 
Analyte 
PWS Headworks 
Lagoon 
8 
MW 
2 
MW 2 
duplicate 
MW 
3 
Field 
Transfer 
ng/L ng/L ng/L ng/L ng/L ng/L ng/L 
 
Sulfamethoxazole 
ND 158 87 1.1 5.8 ND ND 
 
 
Figure 23 Sulfamethoxazole Concentrations from Collected Samples 
Sulfamethoxazole shows a decreasing concentration from process order in the 
wastewater treatment lagoons. The trend in concentration from the headworks to the 
storage lagoon indicates attenuation during treatment, and then further attenuation from 
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the lagoons to MW 2. Utilizing the supporting evidence that MW 2 is connected to the 
lagoons based on the information referenced in Figure 21, the sulfamethoxazole data 
indicates that sulfamethoxazole attenuation occurs from the storage lagoon during 
transport to MW 2. There was no detection of sulfamethoxazole in the blank water field 
transfer or in samples from MW 3. The carbamazepine and sulfamethoxazole data along 
with the isotope data further suggests that MW 3 is not downgradient to the lagoon 
system and is in agreement with the conceptual model. Sulfa drug removal, as discussed 
earlier, is shown to be variable and detectable in effluent and this data supports that 
incomplete removal is occurring. Only about 15-20% of the active drug appears in the 
urine and this population base of 11,000 provides enough sulfamethoxazole to be 
detected in the headworks. These data also suggest, approximately 55% total removal 
efficiency from the headworks to the storage lagoons.  
These data show low dose concentrations of the antibiotic sulfamethoxazole in the 
storage lagoon. As discussed earlier, there is concern over low dose antibiotics in 
wastewater lagoons and the potential for the spread and maintenance of multi-resistance 
bacterial pathogens.  
Sulfamethoxazole is seeping from the lagoons into the perched aquifer in very 
small but detectable concentrations that average 3.5 ng/L.  
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Gemfibrozil 
Gemfibrozil data (Table 10) represented in the column chart shown in Figure 24 
indicates that gemfibrozil was found in the headworks and the storage lagoon but not in 
the perched aquifer.  
Table 10  Gemfibrozil Concentrations from Collected Samples 
Analyte 
PWS Headworks 
Lagoon 
8 
MW 
2 
MW 2 
duplicate 
MW 
3 
Field 
Transfer 
ng/L ng/L ng/L ng/L ng/L ng/L ng/L 
Gemfibrozil ND 440 880 ND ND ND ND 
 
 
Figure 24 Gemfibrozil Concentrations from Collected Samples 
Gemfibrozil is found in treated effluent from various wastewater treatment 
systems and these data show an increasing concentration trend from process order in the 
wastewater treatment lagoons from the headworks to the storage lagoon. Since 
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gemfibrozil is excreted as a metabolite, which was not tested for in this study, the 
increased concentration can plausibly be explained by transformation of metabolites to 
gemfibrozil in the storage lagoons. Additionally, evaporative effects within the storage 
lagoons may lead to increased concentration of gemfibrozil. Analysis of total removal 
efficiency does not apply, as the data shows an apparent increase in concentration during 
the lagoon treatment process. Gemfibrozil has a high hydrophobicity (Table 1) with a log 
[Kow] of 4.77 and its preference to partition to sludge could be explained by this data. 
There was no detection of gemfibrozil in the blank or monitoring wells.  
Estrogens 
There were four estrogens analyzed in the sampling and the data (Table 11) is 
shown in the column chart in Figure 25.  
Table 11  Estrogen Concentrations from Collected Samples 
Analyte 
PWS Headworks 
Lagoon 
8 
MW 
2 
MW 2 
duplicate 
MW 
3 
Field 
Transfer 
ng/L ng/L ng/L ng/L ng/L ng/L ng/L 
 Esterone ND 16 450 120 ND ND ND 
 Estradiol ND ND 49 ND ND ND ND 
 Ethinyl 
Estradiol 17 
alpha 
ND ND 62 9 ND ND ND 
Progestrone  ND 520 ND ND ND ND ND 
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Figure 25 Estrogen Concentrations for Collected Samples 
There was no clear overall trend with the estrogens. Esterone, Estradiol, and 
Ethinyl Estradiol 17alpha show increased concentrations in the storage lagoon. These 
data are indicative of Esterone, Estradiol, and Ethinyl Estradiol 17alpha undergoing de-
conjugation of the metabolite during treatment, thus forming the parent compound. There 
was no analysis for estrogen metabolites, as a consequence a non-detect in the headworks 
of the parent compound (the estrogen), followed by a subsequent detection in the 
treatment process, can indicate that metabolites exist. Estimation of a total removal 
efficiency of this system for estrogens is not possible without the metabolite data. 
Progesterone was only found in the headworks of the treatment system and was not 
detected in other samples, which may indicate treatment in that it either breaks down or is 
partitioning to the sludge during treatment. The log [Kow] of 3.67 (Table 1) predicts a 
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medium to high sorption potential and thus partitioning to the sludge during treatment is 
likely. The sampling data from MW 2 detected only two estrogens, Esterone and 
Estradiol. There were inconsistencies in concentrations analyzed for estrogens in MW 2. 
There is no known explanation for this. The sludge or alluvial materials were not studied 
to determine if estrogens are preferentially partitioning to sludge or breaking down. 
Total Nitrogen 
The wastewater treatment system is designed for nitrogen removal and the data 
(Table 12) as shown in the column chart in Figure 26 indicates that nitrogen removal is 
occurring from the headworks to the storage lagoon. 
Table 12  Total Nitrogen from Collected Samples 
Analyte 
PWS Headworks 
Lagoon 
8 
MW 
2 
MW 
3 
Field 
Transfer 
mg/L mg/L mg/L mg/L mg/L mg/L 
Total Nitrogen 2.7 27.27 14.58 0.63 6.3 ND 
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Figure 26 Total Nitrogen from Samples Collected 
Ground water at MW 2 has a very low total nitrogen concentration. A significant 
decrease in total nitrogen occurs in the vadose zone as seepage moves from the storage 
lagoon to the perched aquifer. At this site, there is an unknown mechanism by which 
nitrogen is being removed from the ground water going to this well. By comparison, 
ground water at MW 3 has a much higher total nitrogen concentration, which indicates 
that the attenuation is not the same mechanism. This supports previous discussed trends 
with isotope and PPCP data, which support that MW 3 is not connected to the lagoons, 
that ground water flow is to the west or southwest from the lagoons, and is in agreement 
with the conceptual model. The source of nitrogen must originate from areas to the east 
or northeast. 
72 
 
 
CONCLUSION 
This study confirmed that during the course of wastewater treatment in a lagoon 
system PPCPs from a small population base are present in inflow to a lagoon treatment 
system and also within the treatment and storage lagoons. Through development of a 
conceptual model and isotope sampling data the study provided evidence of hydraulic 
connectivity between the lagoons and a downgradient ground water monitoring well. 
Furthermore, some PPCPs were shown to have traveled from the lagoons to a 
downgradient ground water site, which is in agreement with the conceptual model. The 
study also suggests that PPCPs may exist as metabolites within the headworks and 
subsequently reform to the biologically active parent compound at later stages of 
treatment and in downgradient ground water. This is a critical point when studying 
compounds such as estrogens, since the metabolites must also be studied in order to form 
a quantitatively accurate study. The transformations of PPCPs makes studying and 
quantifying the PPCPs and their metabolites in a treatment system more complicated. The 
metabolites and their properties may allow for additional environmental pathways of 
transformation. This study did not include metabolites and, as a consequence, limited the 
ability of the study to characterize PPCPs, where metabolites may be present. The PPCP 
detections at this site can help define exposure and add to the data for development of 
models for predicted environmental concentrations and risk assessment. Where 
background environmental levels of biologically active PPCPs exist, the impacts from 
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chronic low dose exposure are relatively unknown in living organisms. Exposure data 
and toxicity data are important pieces of understanding for developing risk and must 
include the effects from a specific PPCP and concomitant exposure. Another area for 
further study is the unintentional exposure of non-target species of PPCPs developed for 
human health benefit and the environmental cascading effects that may occur from those 
affected species. 
This Idaho study of PPCPs in a municipal wastewater treatment lagoon system 
could be expanded. Further studies could be directed in two broad categories. The first 
category could be those studies that concern the specific environment that the PPCPs are 
traveling within and the second category would be the study of the PPCPs within those 
travel pathways. 
Within the first category, the hydrogeology of the study area could be mapped in 
greater detail to further refine the model of potentiometric ground water flow. This could 
be done through the drilling of additional monitoring wells and subsequent monitoring of 
ground water levels. Additional well data could be used to further characterize the vadose 
zone and geologic formations at the study site. Another potential area of study would be 
to examine the plume characteristics within the ground water. This could be 
accomplished by increasing the number of sampling sites. Studies within this category 
would also substantiate the assumptions about the subsurface conditions below the 
lagoons and the ground water flow patterns at this site. 
The second category of studies could include a longitudinal study and quantitative 
analysis of PPCPs and related metabolites in the various stages of treatment along with 
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dye tracer studies to determine the actual mixing that occurs in each lagoon. The lagoon 
sludge could be analyzed for PPCPs to further define the assumptions with hydrophobic 
PPCPs and partitioning to the sludge. The study of this sludge and its life cycle could 
provide important information about PPCP fate and transport. Sludge is often removed 
from lagoons and land applied and there is limited research in this area of study to date. 
The list of PPCPs studied could also be expanded. The regional aquifer downgradient 
from this site could be explored for impacts from PPCPs and other parameters. The 
vadose zone below the lagoons could be defined and core samples taken and analyzed for 
PPCPs.   
Additionally, in this second category of study, the liquid and solid streams of 
exposure could be evaluated based upon their use as nutrients for crops, and assimilation 
of PPCPs within those crops before and after crop harvest and processing. Human 
wastewater has nutrients that become more valuable as land resources become limited 
and agricultural needs grow with the growing world populations. The understanding of 
risk from the liquid and solid streams generated from wastewater treatment is important 
to global sustainability as it applies to wastewater reuse. With wastewater reuse, the 
needs for fresh water sources and ground water recharge must be considered.  
As PPCPs primarily enter into wastewater treatment systems through the sewers, 
reducing the probability of exposure may be an important function of the mitigation 
efforts that should be explored. Concerned communities can immediately attempt to 
reduce loading to sewer systems of PPCPs through community drug take back programs. 
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Studies that begin to identify and quantify the reduced loadings of PPCPs in the sewer 
would be another avenue for exploration in mitigation.   
This study found PPCPs contributed to the environment through municipal 
wastewater lagoon treatment, which adds to the exposure data and supports that further 
study of PPCPs is imperative and of concern. 
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• Donald Bledsoe, Quality Director Idaho Department of Environmental Quality 
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Project Description and Objectives 
This study involves sampling for a selected set of Pharmaceuticals and Personal 
Care Products (PPCP’s) in wastewater before and after treatment, and from existing wells 
in the vicinity of a wastewater treatment and land application site. Limited information 
now exists on the fate of these chemicals in soils and groundwater and this project 
2 
provides a contribution specifically for the state of Idaho that investigates groundwater 
impacts from municipal wastewater sources. Groundwater monitoring from this 
wastewater treatment and land application site will be a reconnaissance mission to answer 
the following questions: Are any of the set of PPCPs present? What concentration are 
they present in? Where were they found? 
Purpose of This Study 
The purpose of this study is to investigate a municipal wastewater land 
application site in Idaho to evaluate contributions of Pharmaceuticals and Personal Care 
Products to groundwater from treated water. The multiple samples from the path of the 
waste water stream will be analyzed for fifteen PPCP’s. These sample data will be used 
to further characterize the fate of the selected set of PPCP’s from municipal waste water 
effluent. Limited information exists on the fate of these PPCP’s in soils and groundwater 
and this project would provide a contribution specifically for the state of Idaho that 
investigate impacts of PPCP’s from municipal wastewater sources.  
Site Criteria 
Sites considered were within the state of Idaho. A site that has a history of 
municipal wastewater application and soils and monitoring well sample results is ideal. A 
site that has a significant population base, enough to provide a diverse pharmaceutical 
and personal contaminant load to a treatment system would also be ideal.  
3 
Wastewater Treatment Methods 
Secondary or tertiary treatment with land application is preferred and lagoons are 
a common treatment system used prior to land application. There are over 7000 
facultative lagoons that serve communities around the United States and a site with 
facultative lagoons may provide information about fate and transport with this treatment 
method.  
Potential Sites Evaluation 
The City of Mountain Home located in Elmore County Idaho may be a good site. 
The City treats municipal waste water in a series of facultative treatment lagoons and 
land applies the treated wastewater to approximately 260 acres of farm ground. There are 
two dedicated monitoring wells down gradient of the treatment lagoons. The site has been 
permitted for land application since 1989.  
The City of Kuna, New Meadows and Calloway Ranch were considered as 
potential sites. The population base and location of groundwater wells make the City of 
Mountain Home site a better choice over these three other sites. 
Site Identification 
The City of Mountain Home sits on a southwest sloping broad flat plateau 3140 
feet above mean sea level. The city has a population of about 11,200 people and treats 
municipal wastewater through lagoon treatment followed by chlorine disinfection and 
then slow rate land application during the growing season (April 1 through October 31). 
The site is approximately 2.5 miles south of the city. Eight facultative lagoons with a 
total volume of 284 million gallons) and an 84 million gallon storage lagoon (s) collect 
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and treat the wastewater from the city. The wastewater application area is comprised of 
five management units (MU). Irrigation pumps apply effluent in accordance with crop 
needs to these fields which are planted with small grain, alfalfa and sugar beets. 
Chlorination automatically runs when the pumps are in operation. Effluent flows from the 
storage lagoon and a chlorine solution is injected through an across the pipe diffuser. It 
then travels about .5 mile to the irrigation pump station. The chlorine contact time is 
provided in this travel time. The number of irrigation lines in use at any particular time 
varies based on crop needs and acreage. Disinfected lagoon effluent is applied to a 258 
acre land application area.  
There are a variety of loam soils on site with varying depths. Depth to ground 
water in the deep regional aquifer is from 200 to 400 feet below land surface. There is 
also a localized perched aquifer in the vicinity of the treatment lagoons that has a depth to 
groundwater of 2 to 40 feet below land surface. This perched aquifer occupies about 
38,000 acres and is found mainly in the clay, silt, sand and gravel of the Quaternary 
Alluvium. The beneficial uses of groundwater in the area are for drinking and agricultural 
irrigation. Recharge to the regional aquifer occurs through precipitation in the mountains 
north of Mountain Home, percolation from ephemeral streams on the plateau and through 
percolation from the perched aquifer. The regional aquifer has permeable zones of highly 
fractured basalt that occur within dense, relatively impermeable flow units. Groundwater 
flow in the regional aquifer is generally in a south to southwest direction. Recharge to the 
perched aquifer occurs from local creeks, irrigation canals and the nearby reservoir. 
Seepage from the wastewater treatment lagoons also provides some recharge to the 
5 
perched aquifer. The direction of ground water movement in the perched aquifer at the 
wastewater treatment site is believed to be to the southwest. 
Project/Task Description 
The purpose of this project is to gain a better understanding of PPCP contaminant 
contributions from wastewater to groundwater. This monitoring will focus on the water 
quality sampling of existing ground water wells and nearby sewer lagoons to further 
characterize impacts by a selected set of PPCPs. Water Samples will be collected over 
two phases. Phase one will involve taking water samples at four locations to serve as 
assessments for contributing concentrations of 15 PPCP’s. Phase two will be determined 
after the results have been assessed for phase one. Phase two will involve sampling 
existing area wells based upon well location, well depth and permission from landowners.  
Specific testing and objectives for both phase one and two are as follows: 
• Onsite field parameters measurements will be evaluated at all water collection 
sites to characterize water properties and evaluate purging effectiveness. Field 
parameters for specific conductance, pH, temperature, and total dissolved solids 
will be measured.  
• Cations and anions will be tested from water samples collected at all monitoring 
sites to evaluate water chemistry to determine variations of potential source water 
and contaminants in the area.  
• Nitrate testing will be completed for all collections sites to determined extent and 
boundaries of nitrate contamination. 
• PPCP sampling for 15 specific analytes will be conducted to determine potential 
influence of wastewater streams contribution of PPCP’s to the environment. 
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• Stable isotope testing samples will be collected and archived for each ground 
water collection site. This testing may provide additional information to delineate 
nitrate sources, ground water recharge sources, and variations in isotopic 
chemistry across the area. 
Quality Objectives and Criteria for Measurement Data 
The objectives of quality assurance and quality control (QA/QC) is to assure that 
analytical results obtained by sample analyses are representative of actual chemical and 
physical compositions of the water samples in the field. Project management will be 
responsible for QA/QC associated with collection of samples, this includes a duplicate 
and field blank for the first four samples taken in phase one. The duplicate will consist of 
sample containers filled with the same composite water from the same sampling site. The 
duplicates will be used to determine both field and laboratory precision. The field blank 
sample is used to determine the integrity of the field sampling events, the condition of the 
sample containers supplied by the laboratory and the accuracy of the laboratory methods. 
Both the duplicates and blank samples are stored and handled with the normal sample 
load for shipment to the laboratory. Laboratory duplicate samples should be within 30% 
of each other. Blank samples should contain below their acceptable values of PPCPs.  
Phase two details for this project are yet to be determined, and the data from 
phase one will be used for decisions on further sampling.  
Project management will provide assurance that the selected analytical 
laboratories will use appropriate QA/QC methods. A laboratory that has met the 
Unregulated Contaminant Monitoring Regulations (UCMR) Laboratory Approval 
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Program application and Proficiency Testing (PT) criteria will be used for assessment of 
PPCP’s. The laboratory will be approved for UCMR 2 and can only use EPA Approved 
laboratory for sampling UCMR using EPA 527, 529, 521, 525.2 and 535 methods for 
PPCP analysis. MWH Laboratories will be used for PPCP sample testing as it has met the 
above requirements. 
The laboratory used for testing of general field parameters is the Idaho Bureau of 
Laboratories which is certified for the chemical and microbiological testing of drinking 
water from public water systems as part of the primacy agreement between the State of 
Idaho and EPA. It is certified for microbiological, organic chemistry and inorganic 
chemistry analytes and methods. 
The laboratory used for isotopes will be the U of Arizona Environmental Isotope 
Laboratory. This laboratory has been used for isotope testing previously for some of the 
sample sites and will be used for consistency. 
Special Training Needs/Certification 
All personnel on the water sampling team will review procedures for using EPA 
Method 1669 (i.e., “clean hands/dirty hands” procedures) for Sampling Ambient Water 
for Trace Metals. This protocol will be modified for sampling trace PPCP’s with 
appropriate considerations for the ability to contaminant water samples with the PPCP’s 
of interest. The intent is to maximize the ability of the field sampling team to collect 
samples reliably and eliminate sample contamination. 
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Documents and Records 
Documentation for this project will include historical data kept on file at DEQ’s 
state office, as well as all documents created for the sampling events addressed under this 
QAPP. The generated documentation will consist of at least those documents developed 
for sample collection procedures, a report summarizing the sampling events and results, 
and this QAPP. Field notebooks and field data sheets will also be kept and included in the 
project file. This information will be available and reviewed by the project management 
for quality control purposes. The data will be recorded using these procedures: 
• Project data must be recorded directly, promptly, and legibly. 
• Field logbook entries must be made in black or blue permanent ink and must be 
initialed and dated by the person making the entry.  
• Changes or corrections to data must be indicated with a single line through the 
original entry.  
A dedicated field logbook will be used to document the following information 
during each sampling event: 
• Purpose of sample event; 
• Make and model of all equipment used; 
• Name of sampling personnel and/or field crew; 
• Identification of the sampling site (e.g., GPS coordinates, benchmark location, 
etc.); 
• Weather conditions and time of arrival at site; 
• Brief description of site conditions, and sampling setup; 
• Date and time of sample collection; 
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• Sample identification numbers and parameters requested; 
• Field parameter measurements and methods;  
• All relevant observations pertaining to each sampling event. 
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DATA GENERATION AND ACQUISITION 
Sampling Process Design (Experimental Design) 
Site and Sampling Procedure 
The wastewater treatment area for the City of Mountain home was chosen for 
Phase One. Four sampling locations were chosen to be sampled in series from the site 
that is assumed to have the least potential of PPCPs to the site that may have the greatest 
potential for highest concentration of PPCPs. Samples will also be taken from Monitoring 
Well 2 then Monitoring Well 3. Afterward, grab samples of wastewater will be collected 
from the last wastewater lagoon in series and then near the head-works or influent to the 
first lagoon. Based on the data collected from phase one of sampling, additional locations 
for sampling will be proposed for phase two, and future revisions to this QAPP.  
At each location, field parameters for specific conductance, pH, temperature, and 
total dissolved solids will be measured. The pH and conductivity meters will be 
calibrated to manufacturer specifications, then measurements will be taken from each 
well while purging. Field parameter measurements will be considered stable when three 
successive measurements taken at intervals of 5 minutes or more differ by the following: 
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specific conductance 5% or less, pH 0.1 unit or less and temperature 0.2 ºC or less, after 
which three sets of samples will be taken to be sent to three different laboratories for each 
sampling site.  
TABLE 1. LABORATORIES 
Laboratory List Parameters Address  
Idaho Bureau of 
Laboratories 
TKN, NH4, NO3-N, Cl, 
SO4, TDS, Total P 
2220 Old Penitentiary Rd 
Boise ID 83712 
U of Arizona 
Environmental Isotope 
Laboratory 
Isotopes: 18O, D, 15N  
Dept. of Geosciences 
Tucson, AZ 852721-0077 
MWH Laboratories PPCP's 
750 Royal Oaks Dr, Ste 
100, Monrovia, CA 
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TABLE 2. SAMPLING CONTAINERS 
Sample Location 
Idaho Bureau 
of 
Laboratories 
U of Arizona 
Environmenta
l Isotope 
Laboratory 
MWH Labs 
Well H2O 
Monitoring 
Well #2 
2 1-
literPolyethyle
ne cubitainers 
1 125 mL 
polyethylene 
Container 
Collect 3 
Samples:  1 
Liter each 
Well H2O 
Monitoring 
Well #3 
2 1-liter 
Polyethylene 
cubitainers 
1 125 mL 
polyethylene 
Container 
Collect 3 
Samples:  1 
Liter each 
Effluent H2O WW Lagoon 8 
2 1-liter 
Polyethylene 
cubitainers 
1 125 mL 
polyethylene 
Container 
Collect 3 
Samples:  1 
Liter each 
Influent H2O 
Headworks/La
goon 1 
2 1-liter 
Polyethylene 
cubitainers 
1 125 mL 
polyethylene 
Container 
Collect 3 
Samples:  1 
Liter each 
Sampling Methods 
The sample procedures described below are designed to very conservatively 
minimize the potential for contamination of the samples. The procedures may be changed 
based on field experiences and future discussions, and minor deviations from these 
procedures will not necessarily invalidate the samples but should be noted within the 
field logbook. 
All field personnel must be extremely conscientious with respect to field and 
sampling techniques while involved with or around collection of samples. Constant care 
and consideration must be exercised to avoid any contamination of the sampling sites or 
sample containers. Prior to donning personal protective equipment (PPE) and/or 
obtaining any sample, field personnel should designate various roles and responsibilities 
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for each member of the sampling team and discuss procedures to be utilized during 
sampling events. Care should be taken not to spill any contaminants (e.g., water, etc.) on 
or near the sampling site, or to let any sampling equipment come into contact with the 
potential contaminants.  
Field personnel will wear powder-less nitrile laboratory gloves during sampling  
and processing. They will change to clean gloves with each change in activity or potential 
glove contamination. They will avoid breathing directly over open samples/equipment. 
They will avoid direct contact between themselves (including clothing) and the sample, 
sampling device, and processing  equipment. Field personnel have been briefed that 
clothing is a source of detergents, fragrances, and fire retardants. On the day of sampling 
activities, they will avoid contact with or consumption of the products listed below: 
• Wastewater compounds such as soaps and detergents, including antibacterial 
cleansers. The laboratory analysis of wastewater includes triclosan, an active 
ingredient in most antibacterial soaps. Triclosan is also commonly found in some 
deodorants, toothpastes, mouthwashes, skin creams, lotions, laundry detergents, 
and dish soaps. 
• Pharmaceutical compounds such as prescription drugs, medications, and 
hormonal substances that are in the list of PPCP’s.  
Upon arrival at the sampling sites one member of the two person sampling team is 
designated as “dirty hands” and the other “clean hands.” The personnel assuming the 
“dirty hands” and “clean hands” roles will don Tyvek coveralls and powderless nitrile 
laboratory gloves, and surgical masks with sampling equipment and containers 
appropriately staged nearby. The dirty hands sampler will observe techniques employed 
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by clean hands personnel and should notify the field team immediately in the event that 
any possible contamination is observed or suspected, or if incorrect sampling techniques 
are utilized.  
The clean hands sampler will touch the sample container and transfer the sample 
from the sample collection device to the sample container. The dirty hands sampler will 
be responsible for the operation of the machinery and all other activities that do not 
involve direct contact with the sample. “Clean hands” places the clean empty sample 
containers, removes the lids of the containers and places the end of the tubing into the 
containers. “Dirty hands” starts the pump. “Clean hands” moves the tubing to a clean 
container. “Dirty hands” stops the pump. “Clean hands” replaces the lid on the container 
and returns the container to the designated place. “Dirty hands” places the bottle into the 
cooler. Gloves are changed between samples and sample sites. After each sample is 
collected, the sample number is documented in the field log along with observations by 
“Dirty hands”.  
Samples should be collected as quickly as is reasonably possible, while carefully 
preventing any contact between the containers and any surface other than the sampling 
surface. Lagoon samples are collected by using a grab sampling technique, through 
immersion into the water by a certified clean amber glass bottle and transferring that into 
the laboratory prepared bottles. The monitoring well samples will be collected using a 
peristaltic pump. The water will be pumped to the surface and the sample containers 
filled directly. Care will be taken to avoid breathing over the sample containers and 
masks will be worn. If any contamination of the sample container occurs or is suspected 
prior to, during, or after sampling, the container in question should not be used in the 
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sampling event, and will be replaced with a new, uncontaminated sample container. Care 
will be taken to avoid contaminating the equipment on site.  
Collected samples will be stored in ice chests with freezer packs to maintain 4oC 
from the time of the sampling event until sample custody is transferred to the lab. MWH 
labs will provide ice chests designated for their samples. DEQ ice chests with ice will be 
used for samples designated for Idaho Bureau of Laboratories and U of Arizona 
Environmental Isotope Laboratory. After leaving the field, samples going to MWH 
laboratory will be packed for shipment and sealed in ice chests with refrigerated packs, 
with the required chain of custody forms. Samples going to Idaho Bureau of Laboratories 
will be dropped off by field personnel and samples going to U of Arizona Environmental 
Isotope Laboratory will be shipped. 
Sample Handling and Custody 
Samples will be directly transported to DEQ headquarters in Boise in coolers with 
cold packs that were previously frozen. These coolers will be shipped overnight to MWH 
Laboratories. All proper chain of custody forms will accompany samples throughout the 
duration of the shipping process.  
After the samples have been collected, they will be placed in an ice chest on 
freezer packs, and held under chain of custody until they are hand delivered to the 
shipping agent. A chain of custody form will accompany each shipment during transport 
to the lab. Each ice chest will be sealed just prior to release of custody, with a completed 
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and properly signed chain of custody form affixed to the inside of the ice chest. The chain 
of custody form will include the following information: 
• Project name/code; 
• Client’s name and address; 
• Laboratory name and address; 
• Sample identification number; 
• Date and time of collection; 
• Type of sample, number of containers, and analysis requested; 
• Sample preservation methods; 
• Field information and remarks; 
• Sample location; 
• Calibration information and procedures; 
• Signature of sample collector(s); 
• Inclusive dates of possession. 
The following procedures will be followed to ensure proper chain of custody: 
• The sample and seal information checked to verify that they match the chain of 
custody form; 
• The chain of custody record will be checked for a signature; 
• A laboratory sample number will be assigned; 
• The sample will be stored in a secure area until it is analyzed. 
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Analytical Methods 
Three different laboratories will be used to analyze the samples. See the following 
tables: 
TABLE 3. MWH LABORATORIES PPCP PARAMETERS AND ACCURACY 
Analytes Description 
Detection Limit 
(ng/L) Test Method 
Caffeine CNS stimulant 1 USGS 2 mod 
Carbamazepine anticonvulsant 5 USGS 2 mod 
Esterone steroid 1 USGS 2 mod 
Esteradiol steroid 1 USGS 2 mod 
Ethinyl Estradiol  steroid 5 USGS 2 mod 
Gemfibrozil  HDL drug 1 USGS 2 mod 
Ibuprofen 
nonsteriod anti 
inflammatory 
1 USGS 2 mod 
Iopromide contrast agent 5 USGS 2 mod 
Progestrone  steriod 1 USGS 2 mod 
Sulfamethoxazole  antibiotic 1 USGS 2 mod 
Testosterone steroid 1 USGS 2 mod 
Trimethoprim 
bacteriostatic 
antibiotic 
1 USGS 2 mod 
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TABLE 4. U OF ARIZONA ENVIRONMENTAL ISOTOPE LABORATORY 
Analytes Method 
18O Isotope Ratio Mass Spectrometry (IRMS)  
   D Isotope Ratio Mass Spectrometry (IRMS)  
15N Isotope Ratio Mass Spectrometry (IRMS)  
TABLE 5. IDAHO BUREAU OF LABORATORIES 
Analytes Method 
Total Kjeldahl Nitrogen, TKN SM 4500-Norg D 
Ammonia as N SM 4500 NH3 H. 
Nitrogen, Nitrate+Nitrite EPA 353.2 
Chloride EPA 300.0 
Sulfate EPA 300.0 
Total Dissolved Solids SM 2540C 
Total Phosphorus 10-115-01-1-F 
Quality Control 
Quality control checks include internal checks for sampling analysis activities, 
duplicate samples and field blanks. Quality Control procedures for the laboratories have 
been certified through the US EPA. The following list documents key components of the 
QA/QC program for this project. 
• Laboratory: The PPCP analytical laboratory will provide appropriate samples 
containers, chain of custody forms, sample labels, and any necessary container 
seals. A laboratory QA/QC report with continuing calibration checks will 
accompany each data report and will be stored in the DEQ state office. DEQ will 
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provide the sample containers that are approved for use in the other two 
laboratories.  
• Sample Collection: All QA/QC procedures for sample collection will be followed 
by sampling personnel. For this sampling project, the QA/QC procedures will be 
fulfilled by adhering to all requirements of Section 2 and such adherence will be 
demonstrated through appropriate documentation of sampling procedures within 
the field logbook. A standard field logbook, dedicated solely for use in this 
project, will be kept for all sampling events and will follow the format described 
in Section 2. 
• Field Duplicates: A duplicate sample will be collected and prepared at one of the 
four sampling sites. All relevant information will be recorded for the duplicates in 
the field logbook. The duplicates will allow assessment of repeatability and 
accuracy of the sampling procedures and will also be used to assist in assessment 
of any cross-contamination issues. Results from the field duplicate analysis will 
be presented in the analytical report. 
• Field Blank: The purpose of the field blank is to assess the amount, if any, of the 
analytes as contaminants that could be collected in sample containers while open 
and exposed during sample collection procedures. The field blank will be 
prepared with a standard supplied by MWH laboratories and shipped from the lab 
with other sample bottles. The field blank will be sent for analysis with other 
samples collected for analysis, and results of the field blank analysis will be 
included in the analytical report. 
Personnel will conduct a field blank procedure at one site, during collection of a 
sample. The same procedures and clean hands/dirty hands techniques used for sample 
collection will generally be observed in handling and preparing the field blank. It is 
critical that the field blank container be isolated from contact with any surfaces or other 
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possible sources of contamination that would have been isolated from contact or exposure 
to the sample containers.  
The clean hands sampler will carefully accept an empty sample container, 
designated as the field blank container, from the dirty hands sampler, and will then open 
and place the container in an appropriate location determined by field personnel. The 
actual location to be used will be determined in the field, based on actual site parameters 
and conditions. The field blank container will be maintained in the vicinity of the 
composite sample collection location, but must be isolated from any situation or location 
that might reasonably be expected to skew or invalidate the purpose of the field blank. 
The clean hands sampler will fill the field blank container with 1 L of standard water 
supplied by MWH Labs prior to collection of the well sample for analysis. The well 
sample procedure will then be conducted per required techniques, exercising care to 
avoid any unnecessary actions that may cause interference with the field blank 
assessment. The field blank container will be kept open throughout the sample collection 
procedure. After the sample has been collected and the container closed, the clean hands 
sampler will seal and then relinquish the field blank container to the dirty hands sampler. 
The identification number of field blank container shall be recorded in the field logbook, 
along with all other required sample information. 
Instrument/Equipment Testing, Inspection, and Maintenance 
Procedures and schedules for preventive maintenance of sampling equipment are 
the responsibility of project management. Each instrument or item of laboratory 
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equipment will be maintained periodically to ensure accuracy. These procedures and 
frequency of performance are designated in the individual instrument manuals. 
TABLE 6. EQUIPMENT TESTING, INSPECTION, AND MAINTENANCE 
REQUIREMENTS 
Equipment Type Inspection Frequency Type of Inspection 
Field parameter meters Daily when in use 
Physical measurement of 
standardized solution prior 
to use in the field. 
Tyvek suits, surgical masks 
and nitrile gloves 
Daily when in use Visual for cuts, tears, etc. 
Sample Bottles Daily when is use 
Visual of PPCP Amber 
bottles that they are sealed 
and appear clean. 
Visual for other parameters 
that they appear clean. 
Instrument/Equipment Calibration and Frequency 
Each instrument or piece of equipment will be calibrated and maintained to ensure 
accuracy within specified limits. The calibration of analysis instrumentation used under 
this project will be the responsibility of the technical personnel assigned to the project. 
The equipment used to collect samples will be calibrated according to manufacturers' 
procedures or internal guidelines at recommended intervals. Calibration sheets that 
contain the calibration procedures and the results of each calibration, or the equivalent, 
will be kept on file. The calibration sheets will also serve as a permanent record of 
maintenance for the sampling equipment.  
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TABLE 7. EQUIPMENT CALIBRATION REQUIREMENTS 
Equipment Type Calibration Frequency 
Standard or Calibration 
Instrument Used 
Field parameter meter Prior to sampling round 
Standardized calibration 
fluid 
Inspection/Acceptance of Supplies and Consumables 
Sample containers, labels and associated preservatives will be provided by MWH 
laboratories. Instructions provided by MWH laboratories will be followed throughout the 
duration of the project.  
Data Management 
The sampling team is responsible for collection, storage, and transport of field 
data to the office. A standard system for sample labeling and correlation with appropriate 
field notes and QC checks will be developed. Laboratory and field data will be compiled 
by project management.  
Hard copies of all field notes and field data sheets will be kept on record at the 
DEQ office. All information pertaining to this project will be stored in the source files, 
and electronic copies of all reports will be available for review upon request. 
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ASSESSMENT AND OVERSIGHT 
Assessments and Response Actions 
The purpose of assessment is to ensure that this plan is implemented as 
prescribed. 
The quality director will have the lead role in assessing the QA and QC measures 
employed in this study (e.g. review of sampling procedures). The two project mangers 
will work together to determine appropriate QA and QC measures. They will also have 
the lead role in data quality review. Both will work together to assure overall project 
objectives are met. 
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Reports to Management 
The final field report will be prepared by the project manager and will include: 
• A summary of the field work conducted 
• The results of the laboratory analyses, including quality assurance measures 
• A QA and QC summary  
• Conclusions 
No specific action will be required by any recipient of the report. 
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DATA VALIDATION AND USABILITY 
Data Review, Verification, and Validation 
The objectives of this project are to provide information to determine if any of the 
set of PPCPs present is present in the wastewater and groundwater at this site? What 
concentration are they present in? Where were they found? This important information 
for validation concerns the sampling methods. Verification requirements concern the 
quality of the actual data and interpretation of the data. Compliance with sampling 
protocol, record keeping, labeling as defined in this document constitute the requirements 
for verification.  
Verification and Validation Methods 
The project managers will be responsible for reviewing the project, collecting 
samples, labeling, storage, transport, sending the samples for analysis and summarizing 
the data. They will confirm that the data generated complied with the specifications fo the 
procedures and objectives of the proposal. Any deviations will be noted and whether to 
reject, accept or qualify the data will be determined. Data will be subject to visual 
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inspection and any questions as to values or sample identity will be resolved via line-by-
line confirmation with the analyzing laboratory.  
Reconciliation with User Requirements 
Data and conclusions will be peer reviewed at both at DEQ and Boise State 
University. The peer-review process is set up to identify technical and scientific concerns. 
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REPORT OF ANALYSES
4 water samples for N, O and H isotopes
Sample ID W δ18O ‰ δD ‰ δ15N ‰
1 (MW-3) 36140 -14.5 -116 14.6
2 (MW-2) 36141 -7.6 -83 7.8
4 (Lagoon 8) 36142 -7.0 -79 10.6
5 (Headworks) 36143 -16.0 -124 0.9
Analytical Precision (1-sigma) 0.08 0.9 0.15
C.J.Eastoe
Staff Scientist
